<!DOCTYPE article
PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD with MathML3 v1.3 20210610//EN" "JATS-archivearticle1-3-mathml3.dtd">
<article xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" article-type="review-article" dtd-version="1.3"><?properties open_access?><processing-meta base-tagset="archiving" mathml-version="3.0" table-model="xhtml" tagset-family="jats"><restricted-by>pmc</restricted-by></processing-meta><front><journal-meta><journal-id journal-id-type="nlm-ta">Int J Retina Vitreous</journal-id><journal-id journal-id-type="iso-abbrev">Int J Retina Vitreous</journal-id><journal-title-group><journal-title>International Journal of Retina and Vitreous</journal-title></journal-title-group><issn pub-type="epub">2056-9920</issn><publisher><publisher-name>BioMed Central</publisher-name><publisher-loc>London</publisher-loc></publisher></journal-meta>
<article-meta><article-id pub-id-type="pmid">39891221</article-id><article-id pub-id-type="pmc">PMC11786548</article-id><article-id pub-id-type="publisher-id">618</article-id><article-id pub-id-type="doi">10.1186/s40942-024-00618-5</article-id><article-categories><subj-group subj-group-type="heading"><subject>Review</subject></subj-group></article-categories><title-group><article-title>The role of optical coherence tomography angiography in assessing diabetic choroidopathy: a systematic review</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Nowroozzadeh</surname><given-names>M. Hossein</given-names></name><xref ref-type="aff" rid="Aff1">1</xref></contrib><contrib contrib-type="author" corresp="yes"><name><surname>Bagheri</surname><given-names>Mansoureh</given-names></name><address><email>mansoureh.bagheri.ca@gmail.com</email></address><xref ref-type="aff" rid="Aff1">1</xref><xref ref-type="aff" rid="Aff2">2</xref></contrib><aff id="Aff1"><label>1</label><institution-wrap><institution-id institution-id-type="ROR">https://ror.org/01n3s4692</institution-id><institution-id institution-id-type="GRID">grid.412571.4</institution-id><institution-id institution-id-type="ISNI">0000 0000 8819 4698</institution-id><institution>Poostchi Ophthalmology Research Center, Department of Ophthalmology, School of Medicine, </institution><institution>Shiraz University of Medical Sciences, </institution></institution-wrap>Shiraz, Iran </aff><aff id="Aff2"><label>2</label><institution-wrap><institution-id institution-id-type="ROR">https://ror.org/05yb43k62</institution-id><institution-id institution-id-type="GRID">grid.436533.4</institution-id><institution-id institution-id-type="ISNI">0000 0000 8658 0974</institution-id><institution>Department of Surgical Subspecialties, Service of Ophthalmology at Health Sciences North, </institution><institution>Northern Ontario School of Medicine University, </institution></institution-wrap>Sudbury, ON P3E 5J1 Canada </aff></contrib-group><pub-date pub-type="epub"><day>31</day><month>1</month><year>2025</year></pub-date><pub-date pub-type="pmc-release"><day>31</day><month>1</month><year>2025</year></pub-date><pub-date pub-type="collection"><year>2025</year></pub-date><volume>11</volume><elocation-id>10</elocation-id><history><date date-type="received"><day>16</day><month>10</month><year>2024</year></date><date date-type="accepted"><day>8</day><month>12</month><year>2024</year></date></history><permissions><copyright-statement>&#x000a9; The Author(s) 2024</copyright-statement><copyright-year>2024</copyright-year><license><ali:license_ref specific-use="textmining" content-type="ccbylicense">https://creativecommons.org/licenses/by/4.0/</ali:license_ref><license-p><bold>Open Access</bold> This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article&#x02019;s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article&#x02019;s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit <ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by/4.0/">http://creativecommons.org/licenses/by/4.0/</ext-link>. The Creative Commons Public Domain Dedication waiver (<ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/publicdomain/zero/1.0/">http://creativecommons.org/publicdomain/zero/1.0/</ext-link>) applies to the data made available in this article, unless otherwise stated in a credit line to the data.</license-p></license></permissions><abstract id="Abs1"><sec><title>Background</title><p id="Par1">Diabetic retinopathy (DR) is a leading cause of vision impairment worldwide, affecting both retinal and choroidal vasculature. While advances in imaging technology, particularly optical coherence tomography angiography (OCTA), provide new opportunities to assess choroidal changes in diabetic patients, the role of OCTA in early diagnosis and monitoring of diabetic choroidopathy remains unclear.</p></sec><sec><title>Objective</title><p id="Par2">This review aims to evaluate the potential role of OCTA in diagnosing and monitoring diabetic choroidopathy.</p></sec><sec><title>Methods</title><p id="Par3">A systematic review was conducted following Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) 2020 guidelines. Databases including PubMed, Embase, Cochrane Library, Google Scholar, ISI, and Scopus were searched for studies on diabetic choroidopathy assessed by OCTA. Studies included were peer-reviewed, published in English, and excluded case reports, conference proceedings, and studies on treated DR patients. Two independent reviewers screened articles for eligibility based on predefined criteria.</p></sec><sec><title>Results</title><p id="Par4">OCTA allows for non-invasive, high-resolution visualization of retinal and choroidal microvasculature, providing both qualitative and quantitative data. The majority of studies indicate a significant decrease in choroidal perfusion parameters in diabetic patients without DR compared to healthy controls. Conflicting evidence exists regarding the correlation between choriocapillaris flow reduction and DR severity. OCTA may also predict changes in visual function related to choroidal perfusion, though it cannot fully replace clinical examinations.</p></sec><sec><title>Conclusions</title><p id="Par5">OCTA is a valuable tool for early detection and monitoring of diabetic choroidopathy. However, its role is limited by variability in findings and its inability to detect certain features of diabetic microangiopathy. Further studies are needed to clarify its clinical utility and standardize assessment methods.</p></sec><sec><title>Supplementary Information</title><p>The online version contains supplementary material available at 10.1186/s40942-024-00618-5.</p></sec></abstract><kwd-group xml:lang="en"><title>Keywords</title><kwd>Choriocapillaris</kwd><kwd>Choroidal vasculature</kwd><kwd>Diabetic choroidopathy</kwd><kwd>Diabetic retinopathy</kwd><kwd>Optical coherence tomography angiography</kwd></kwd-group><custom-meta-group><custom-meta><meta-name>issue-copyright-statement</meta-name><meta-value>&#x000a9; Brazilian Retina and Vitreous Society 2025</meta-value></custom-meta></custom-meta-group></article-meta></front><body><sec id="Sec1"><title>Background</title><p id="Par10">Diabetic chorioretinopathy, a leading cause of acquired vision impairment worldwide, affects both the retinal and choroidal vasculature [<xref ref-type="bibr" rid="CR1">1</xref>]. Histopathologic studies of diabetic choroidopathy have demonstrated arteriosclerotic changes in choroidal vessels and alterations in the choriocapillaris, including capillary dropout, which lead to ischemic changes in the outer retinal layers [<xref ref-type="bibr" rid="CR2">2</xref>, <xref ref-type="bibr" rid="CR3">3</xref>]. Diabetes may also cause basement membrane thickening around the choriocapillaris, microaneurysm formation, and narrowing or even obstruction of the choroidal vasculature, all contributing to macular dysfunction [<xref ref-type="bibr" rid="CR2">2</xref>, <xref ref-type="bibr" rid="CR4">4</xref>]. However, choroidal imaging in diabetic patients, particularly in the early stages of diabetic retinopathy (DR), remains underutilized due to the inherent challenges of visualizing the choroid in vivo [<xref ref-type="bibr" rid="CR1">1</xref>, <xref ref-type="bibr" rid="CR5">5</xref>].</p><p id="Par11">Historically, imaging modalities such as Indocyanine green angiography (ICGA) and Fluorescein angiography have been employed to detect vascular changes in diabetic choroidopathy [<xref ref-type="bibr" rid="CR5">5</xref>]. Despite their utility, these methods are considered invasive and may not be ideal for visualizing the choriocapillaris due to their limited capacity for depth resolution and lateral imaging [<xref ref-type="bibr" rid="CR5">5</xref>]. For instance, although selective choriocapillaris filling on ICGA has been suggested as a marker of early diabetic choroidopathy, it lacks the resolution and depth-resolved imaging needed for precise quantification of choriocapillaris flow [<xref ref-type="bibr" rid="CR6">6</xref>].</p><p id="Par12">Advances in imaging technology, particularly optical coherence tomography angiography (OCTA), offer new possibilities for investigating the pathophysiologic effects of diabetes on the choroidal vasculature in vivo [<xref ref-type="bibr" rid="CR7">7</xref>]. OCTA utilizes motion contrast imaging to detect moving erythrocytes, causing decorrelation of pixels in sequential optical coherence tomography (OCT) B-scans, which correlates with blood flow velocity [<xref ref-type="bibr" rid="CR5">5</xref>]. OCTA indices have demonstrated high precision in identifying microvascular changes in both the retinal and choroidal regions, often before detectable fundus or clinical signs appear [<xref ref-type="bibr" rid="CR5">5</xref>, <xref ref-type="bibr" rid="CR8">8</xref>]. Previous studies have reported a significant reduction in choroidal vascular perfusion in diabetic patients compared to healthy controls [<xref ref-type="bibr" rid="CR9">9</xref>, <xref ref-type="bibr" rid="CR10">10</xref>]. This review article aims to evaluate and highlight the potential role of OCTA in the diagnosis and monitoring of diabetic choroidopathy.</p></sec><sec id="Sec2"><title>Methods</title><p id="Par13">This systematic review was conducted following the guidelines set by the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) 2020 statement [<xref ref-type="bibr" rid="CR11">11</xref>]. Two independent reviewers performed a comprehensive search across multiple databases, including PubMed, Embase, the Cochrane Library Central Register of Controlled Trials, Google Scholar, ISI, and Scopus. The most recent search was conducted on September 23, 2024. The search strategy included the terms &#x0201c;OCTA&#x0201d; OR &#x0201c;OCT angiography&#x0201d; OR &#x0201c;optical coherence tomography angiography&#x0201d; AND &#x0201c;diabetes&#x0201d; OR &#x0201c;diabetes mellitus&#x0201d; OR &#x0201c;diabetic choroidopathy&#x0201d; OR &#x0201c;diabetic vasculopathy&#x0201d; OR &#x0201c;diabetic angiopathy&#x0201d;, incorporating both MeSH terms and relevant synonyms.</p><p id="Par14">The review included studies that specifically investigated alterations in choroidal vasculature attributed to diabetes using OCTA. Only articles published in English in peer-reviewed journals were considered, while case reports, abstracts, conference proceedings, letters, and duplicated studies were excluded. No restrictions were placed on age, type of diabetes or its control, or follow-up duration. Studies involving OCTA findings in diabetic patients who had received treatment for DR, including laser therapy or intraocular injections, were also excluded.</p><p id="Par15">Titles and abstracts of all retrieved articles were screened independently by two reviewers to identify those meeting the predefined inclusion and exclusion criteria. Articles selected from this initial screening underwent a second, more detailed evaluation of their full texts to confirm compliance with the eligibility criteria (Fig.&#x000a0;<xref rid="Fig1" ref-type="fig">1</xref>).</p><p id="Par16">
<fig id="Fig1"><label>Fig. 1</label><caption><p>Systematic review flow diagram on the role of optical coherence tomography angiography in assessing diabetic choroidopathy</p></caption><graphic xlink:href="40942_2024_618_Fig1_HTML" id="d33e387"/></fig>
</p><p id="Par17">For quality assessment, we employed the Newcastle-Ottawa Scale for evaluating cohort and case-control studies. The Newcastle-Ottawa Scale is a star-based rating system that assesses studies across three broad categories: exposure, comparability, and outcome, with a maximum score of nine stars [<xref ref-type="bibr" rid="CR12">12</xref>].</p></sec><sec id="Sec3" sec-type="results"><title>Results</title><p id="Par18">Tables&#x000a0;<xref rid="Tab1" ref-type="table">1</xref> and <xref rid="Tab2" ref-type="table">2</xref> summarize the characteristics and findings of previous cohort, cross-sectional and case-control studies on the role of OCTA in assessing diabetic choroidopathy.</p><p id="Par19">
<table-wrap id="Tab1"><label>Table 1</label><caption><p>Summary of cohort studies on the role of OCTA in assessing diabetic choroidopathy</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left">Study</th><th align="left">Newcastle-Ottawa Quality Assessment scale</th><th align="left">Device</th><th align="left">Population<break/>Sample size</th><th align="left">Outcome measures</th><th align="left">Findings</th></tr></thead><tbody><tr><td align="left">Fragiotta et al. 2023 [<xref ref-type="bibr" rid="CR28">28</xref>]</td><td align="left">6</td><td align="left">SS-OCTA</td><td align="left">-T1DM with mild NPDR: 22 cases (22 eyes)</td><td align="left"><p>-OCTA: CC FD %</p><p>-AO: CD, LDi, and HPi</p><p>-Fu: 4 y</p></td><td align="left"><p>- The CC FD exhibited a consistent increase over time (<italic>P</italic>&#x000a0;&#x0003c; 0.01).</p><p>- The LDi and HPi were primarily impacted by choriocapillaris perfusion in the parafovea (<italic>P</italic>&#x000a0;= 0.02).</p><p>- There was progressive deterioration of cone metrics over time due to worsening CC perfusion deficit.</p></td></tr><tr><td align="left">Chen et al. 2023 [<xref ref-type="bibr" rid="CR44">44</xref>]</td><td align="left">6</td><td align="left">SS-OCTA</td><td align="left">-T2DM without DR or with mild NPDR (no DME): 903 cases</td><td align="left"><p>-CC FD%</p><p>-&#x02265;2 steps DR progression or development of DME</p><p>-Fu: 3 y</p></td><td align="left"><p>&#x02212;&#x02009;16.34% developed DR progression, and 6.54% developed DME.</p><p>- A higher average CC FD% was correlated with DR progression (OR, 3.41 per SD increase, 95% CI: 2.65&#x02013;4.39, <italic>P</italic>&#x02009;&#x0003c;&#x02009;0.001) and DME development (OR, 1.37 per SD increase, 95% CI: 1.06&#x02013;1.77, <italic>P</italic>&#x02009;=&#x02009;0.016) (especially in the inferior field) after adjusting for confounders.</p></td></tr><tr><td align="left">Guo et al. 2023 [<xref ref-type="bibr" rid="CR45">45</xref>]</td><td align="left">6</td><td align="left">SS-OCTA</td><td align="left">-T2DM without DR or with mild NPDR (no DME): 946 cases (1879 eyes)</td><td align="left"><p>-Parapapillary (3-mm) CC FD%</p><p>-&#x02265;2 steps DR progression or development of DME</p><p>-Fu: 3 y</p></td><td align="left"><p>&#x02212;&#x02009;16.60% experienced DR progression and 6.12% developed DME.</p><p>- The DR progression was related to an elevated CC FD% (1.62, 1.40&#x02013;1.88; <italic>P</italic>&#x02009;&#x0003c;&#x02009;0.001).</p><p>- The DME occurrence was associated with a higher CC FD% (1.29, 1.03&#x02013;1.61; <italic>P</italic>&#x02009;&#x0003c;&#x02009;0.001).</p></td></tr><tr><td align="left">Wang et al. 2022 [<xref ref-type="bibr" rid="CR40">40</xref>]</td><td align="left">4</td><td align="left">SS-OCTA</td><td align="left">-T2DM: 1222 patients (1222 eyes)</td><td align="left"><p>-CC FD%</p><p>-1-year incidence of RDR</p></td><td align="left">- Each 1% increase in baseline CC FD% was associated with 1.69 times (RR 2.69; 95% CI 1.53 to 4.71; <italic>p</italic>&#x02009;=&#x02009;0.001) higher risk for development of RDR after 1 year.</td></tr></tbody></table><table-wrap-foot><p>AO, adaptive optics; CC, choriocapillaris; CD, cone density; CCFV, choriocapillaris flow void; DR, diabetic retinopathy; DME, diabetic macular edema; FD, flow deficit; FU, follow-up; HPi, heterogeneity packing index; LDi, linear dispersion index; NPDR, non-proliferative diabetic retinopathy; OCTA, optical coherence tomography angiography; OR, odds ratio; RDR, proliferative diabetic retinopathy; RR, relative risk; SD, standard deviation; SS-OCTA, swept-source optical coherence tomography angiography; T1DM, type 1 diabetes mellitus; T2DM, type 2 diabetes mellitus</p></table-wrap-foot></table-wrap>
</p><p id="Par20">
<table-wrap id="Tab2"><label>Table 2</label><caption><p>Summary of cross-sectional and case-control studies on the role of OCTA in assessing diabetic choroidopathy</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left">Study<break/>(Quality)</th><th align="left">Newcastle-Ottawa Quality Assessment scale</th><th align="left">Device</th><th align="left">Population<break/>Sample size</th><th align="left">Outcome measures</th><th align="left">Findings</th></tr></thead><tbody><tr><td align="left">Thaker et al. 2023 [<xref ref-type="bibr" rid="CR29">29</xref>]</td><td align="left">N/A</td><td align="left">SS-OCTA</td><td align="left">NPDR: 110 patients (176 eyes)</td><td align="left">-Choroid circulation flow void</td><td align="left"><p>- Choroid circulation flow void</p><p>was significantly associated with more severe NPDR.</p></td></tr><tr><td align="left">Bandello et al. 2023 [<xref ref-type="bibr" rid="CR50">50</xref>]</td><td align="left">9</td><td align="left"/><td align="left"><p>-Total: 60 cases</p><p>-Treatment-na&#x000ef;ve mild DR (ETDRS 20&#x02013;35): 30</p><p>-HC: 30</p></td><td align="left"/><td align="left">The CC FD% was associated with foveal mesopic sensitivity (&#x003b2;: -0.234, <italic>p</italic>&#x02009;=&#x02009;0.046), parafoveal mesopic sensitivity (&#x003b2;: -0.312, <italic>p</italic>&#x02009;=&#x02009;0.032), and parafoveal dark-adapted sensitivity (&#x003b2;: -0.282, <italic>p</italic>&#x02009;=&#x02009;0.048).</td></tr><tr><td align="left">Deng et al. 2023 [<xref ref-type="bibr" rid="CR31">31</xref>]</td><td align="left">9</td><td align="left"/><td align="left"><p>-T2DM (not severe DR, no DME): 102 cases (194 eyes)</p><p>-HC: 28 cases (56 eyes)</p></td><td align="left"><p>-CCF</p><p>-ERG</p></td><td align="left"><p>- CCF was decreased from the control to the nondiabetic retinopathy (NDR) to DR group.</p><p>In patients with diabetes, CCF was correlated with ERG parameters (coefficient index=-0.601, <italic>P</italic>&#x02009;&#x0003c;&#x02009;0.001 with 16 Td-s implicit time; coefficient index=-0.687, <italic>P</italic>&#x02009;&#x0003c;&#x02009;0.001 with 32 Td-s implicit time; coefficient index&#x02009;=&#x02009;0.933, <italic>P</italic>&#x02009;=&#x02009;0.035 with 32 Td-s amplitude).</p><p>CCF was correlated with the RPE thickness and the level of HbA1c (both <italic>P</italic>&#x02009;=&#x02009;0.001).</p></td></tr><tr><td align="left">Wang et al. 2023 [<xref ref-type="bibr" rid="CR30">30</xref>]</td><td align="left">N/A</td><td align="left">SS-OCTA</td><td align="left">-T2DM: 1692 cases</td><td align="left"><p>-CC FD density</p><p>-CC FD size</p><p>-CC FD number</p></td><td align="left"><p>- After controlling for confounding factors, individuals with DR had a significantly higher FD density compared to those without DR. Specifically, the differences were 1.61% (95% CI 1.04 to 2.18; <italic>p</italic>&#x02009;&#x0003c;&#x02009;0.001) for individuals with mild NPDR, 2.23% (95% CI 1.76 to 2.70; <italic>p</italic>&#x02009;&#x0003c;&#x02009;0.001) for those with moderate NPDR, and 3.31% (95% CI 2.27 to 4.36; <italic>p</italic>&#x02009;&#x0003c;&#x02009;0.001) for those with severe NPDR, compared to individuals without DR.</p><p>- The higher FD number and size were correlated with more severer degrees of DR (all <italic>p</italic>&#x02009;&#x0003c;&#x02009;0.05).</p><p>- Adding FD density to conventional risk factors significantly improved the ability to distinguish DR from NDR patients, with an AUC of 0.829 (95% CI 0.804 to 0.855; <italic>p</italic>&#x02009;&#x0003c;&#x02009;0.001).</p></td></tr><tr><td align="left">Viggiano et al. 2023 [<xref ref-type="bibr" rid="CR52">52</xref>]</td><td align="left">9</td><td align="left">SS-OCTA</td><td align="left"><p>-T1DM (<italic>n</italic>&#x02009;=&#x02009;40) including:</p><p>NDR: 12, and</p><p>mild NPDR: 28</p><p>-HC: 10</p></td><td align="left"><p>-OCTA: CC FD%</p><p>-AO: CD, LDi, HPi</p></td><td align="left"><p>- A close relationship was showed between cone metrics and CC FD in NPDR group.</p><p>- The percentage increase in CC FD was linked to an increase in LDi (<italic>p</italic>&#x02009;=&#x02009;0.035). Moreover, the rise in CC FD% was found to be correlated with a decrease in CD (<italic>p</italic>&#x02009;=&#x02009;0.042) and HPi (<italic>p</italic>&#x02009;=&#x02009;0.017).</p></td></tr><tr><td align="left">Tan et al. 2023[<xref ref-type="bibr" rid="CR20">20</xref>]</td><td align="left">8</td><td align="left"/><td align="left"><p>-HC: 27 cases (35 eyes)</p><p>-DM: 75 cases (132 eyes), including:</p><p>NDR: 62 eyes</p><p>NPDR: 51 eyes, and</p><p>PDR: 19 eyes</p></td><td align="left"><p>-CC flow void density, %</p><p>(3*3&#x000a0;mm; fovea-centered)</p></td><td align="left"><p>- CC parameters were strongly altered with DR stages (<italic>p</italic>&#x02009;&#x0003c;&#x02009;0.01).</p><p>- The CC parameters were more effective in distinguishing between the group with no DM &#x00026; NDR, compared to the retinal parameters (with AUC of 0.954 vs. 0.821, <italic>p</italic>&#x02009;=&#x02009;0.006).</p><p>- Combining both retinal and choroidal microvasculature parameters in a classification model resulted in a significant enhancement in distinguishing between DR and the absence of DR, compared to using each parameter independently (<italic>p</italic>&#x02009;=&#x02009;0.029).</p></td></tr><tr><td align="left">Xiong et al. 2022 [<xref ref-type="bibr" rid="CR17">17</xref>]</td><td align="left">9</td><td align="left">SS-OCTA</td><td align="left"><p>-DM: 71 cases</p><p>-High myopia: 71</p><p>-DM&#x02009;+&#x02009;High myopia: 71</p><p>-HC: 71</p></td><td align="left">-CC perfusion index</td><td align="left">The mean CC perfusion index for the control, diabetes, high myopia, and diabetes with high myopia groups were 91.11&#x02009;&#x000b1;&#x02009;0.84%, 90.16&#x02009;&#x000b1;&#x02009;1.46%, 89.80&#x02009;&#x000b1;&#x02009;1.42%, and 89.36&#x02009;&#x000b1;&#x02009;1.19%, respectively (<italic>P</italic>&#x02009;&#x0003c;&#x02009;0.001).</td></tr><tr><td align="left">Kaderil et al. 2022 [<xref ref-type="bibr" rid="CR49">49</xref>]</td><td align="left">N/A</td><td align="left">SD-OCTA</td><td align="left"><p>-Total: 58 patients (95 eyes), including:</p><p>1- NPDR: 59</p><p>2- PDR: 36 (2&#x000a0;A: VA&#x02009;&#x02264;&#x02009;0.2 logMAR; 2B: &#x0003e; 0.2)</p></td><td align="left">-CC plexus flow area</td><td align="left">- CCP flow area was lower in group 2B (All, <italic>p</italic>&#x02009;&#x0003c;&#x02009;0.05).</td></tr><tr><td align="left">Liu et al. 2022 [<xref ref-type="bibr" rid="CR41">41</xref>]</td><td align="left">7</td><td align="left">SS-OCTA</td><td align="left"><p>-NPDR: 42 cases (71 eyes)</p><p>-PDR: 31 cases (53 eyes)</p><p>-HC: 30 cases (51 eyes)</p></td><td align="left">-choroid perfusion</td><td align="left">- The choroid perfusion exhibited significant differences across different areas and amongst the three groups.</td></tr><tr><td align="left">Zhang et al.,2021 [<xref ref-type="bibr" rid="CR10">10</xref>]</td><td align="left">7</td><td align="left"/><td align="left"><p>-36 diabetic patients (54 eyes), including:</p><p>NDR: 31 eyes, Mild NPDR: 19 eyes, and</p><p>Moderate NPDR: 4 eyes</p><p>-32 control subjects (54 healthy eyes)</p></td><td align="left">-CC blood flow signal density</td><td align="left">Within the diabetic group, the CC blood flow signal density in the macular area (diameter&#x02009;=&#x02009;2000&#x000a0;&#x003bc;m) exhibited a significant reduction compared to the healthy control group (<italic>P</italic>&#x02009;&#x0003c;&#x02009;0.05).</td></tr><tr><td align="left">Ryu et al. 2021 [<xref ref-type="bibr" rid="CR39">39</xref>]</td><td align="left">7</td><td align="left"/><td align="left"><p>-DM NDR: 49</p><p>-NPDR: 51</p><p>-PDR: 38</p><p>-HC: 52</p></td><td align="left">-CC vessel density</td><td align="left"><p>In NDR group, CC vessel density was found to be decreased only in the perifoveal area (with p-values of 0.823 for the foveal area, 0.631 for the parafoveal area [1&#x02013;3&#x000a0;mm], and 0.039 for the perifoveal area [3&#x02013;6&#x000a0;mm]).</p><p>Multivariate linear regression analyses showed significant associations between DR severity and all retinal and choroidal microvascular indices.</p></td></tr><tr><td align="left">Zlatanovi&#x00107; et al. 2021 [<xref ref-type="bibr" rid="CR16">16</xref>]</td><td align="left">8</td><td align="left">SD-OCTA</td><td align="left"><p>-T2DM without DR: 83 cases (166 eyes); age: 59&#x02009;&#x000b1;&#x02009;14 y</p><p>-HC: 33 cases (66 eyes)</p></td><td align="left">-CC flow area and vessel density</td><td align="left">- There was a statistically significant reduction in the CC flow area and vessel density in the NDR group compared to healthy subjects.</td></tr><tr><td align="left">Parravano et al. 2021 [<xref ref-type="bibr" rid="CR53">53</xref>]</td><td align="left">N/A</td><td align="left"/><td align="left"><p>-T1DM, including:</p><p>NDR: 18</p><p>NPDR: 25</p></td><td align="left"><p>-EZ &#x0201c;normalized&#x0201d; reflectivity,</p><p>-mfERG rRADs</p><p>-FDn, FDa, &#x00026; FD%</p></td><td align="left"><p>-The mean values for EZ &#x0201c;normalized&#x0201d; reflectivity, mfERG RAD, CC FDn, and FD% were not significantly different between the NPDR and NDR groups (<italic>p</italic>&#x02009;&#x0003e;&#x02009;0.05), but FDa was significantly higher in NPDR eyes (<italic>p</italic>&#x02009;&#x0003c;&#x02009;0.05).</p><p>-In NPDR eyes, there was a significant linear relationship between decreased mfERG RADs and increase in either CC FDa and FD%.</p><p>-In NDR eyes, EZ &#x0201c;normalized&#x0201d; reflectivity was negatively correlated with CC FD%.</p></td></tr><tr><td align="left">Stulova et al. 2021 [<xref ref-type="bibr" rid="CR19">19</xref>]</td><td align="left">7</td><td align="left"/><td align="left"><p>-T1DM NDR: 41 patients (76 eyes)</p><p>-HC: 31 (55 eyes)</p></td><td align="left">-CC FDs</td><td align="left">-Patients with T1DM showed an increase in both the density and mean size of FDs.</td></tr><tr><td align="left">Ra et al. 2021 [<xref ref-type="bibr" rid="CR42">42</xref>]</td><td align="left">N/A</td><td align="left"/><td align="left"><p>-T2DM: 152 cases (282 eyes), including:</p><p>NDR: 114</p><p>NPDR: 79</p><p>S-NPDR: 48</p><p>PDR: 41</p></td><td align="left"><p>-CC vascular density</p><p>-Choroidal vascular density</p></td><td align="left"><p>-CC vascular density was lower in patients with PDR compared to those with NPDR (<italic>P</italic>&#x02009;&#x0003c;&#x02009;0.05).</p><p>-Significant positive correlations were found between superficial and deep retinal vascular density and CC vascular density (all <italic>P</italic>&#x02009;&#x0003c;&#x02009;0.001), while choroidal vascular density showed negative correlations with these parameters (also <italic>P</italic>&#x02009;&#x0003c;&#x02009;0.001).</p><p>-Both retinal and CC vascular density were negatively correlated with diabetic retinopathy grade (all <italic>P</italic>&#x02009;&#x0003c;&#x02009;0.001), while choroidal vascular density had a weak positive correlation (<italic>P</italic>&#x02009;=&#x02009;0.030).</p></td></tr><tr><td align="left">Ucgul et al. 2021 [<xref ref-type="bibr" rid="CR55">55</xref>]</td><td align="left">N/A</td><td align="left"/><td align="left"><p>-T2DM, including:</p><p>NDR without MA: 20,</p><p>NDR&#x02009;+&#x02009;MA: 20, and</p><p>Mild NPDR&#x02009;+&#x02009;MA:30</p></td><td align="left">- CC vascular density</td><td align="left">There were significant inverse correlations between diabetes duration, creatinine, urea, serum Na, and certain CC vessel density values (with p-values below 0.05 for all correlations).</td></tr><tr><td align="left">Ghassemi et al. 2021 [<xref ref-type="bibr" rid="CR43">43</xref>]</td><td align="left">N/A</td><td align="left"/><td align="left"><p>-DR</p><p>97 cases (188 eyes)</p></td><td align="left">-CC vascular density (macula 3*3&#x000a0;mm)</td><td align="left"><p>- There was a consistent pattern of decreasing CC vascular density from normal cases to cases of NDR and NPDR, followed by a slight increase in the PDR stage, but the vascular density never reached normal levels.</p><p>- BCVA was positively correlated with CC vascular density of foveal area.</p></td></tr><tr><td align="left">Agra et al. 2021 [<xref ref-type="bibr" rid="CR27">27</xref>]</td><td align="left">8</td><td align="left"/><td align="left"><p>-T2DM NDR: 30 cases (30 eyes)</p><p>-HC: 30 cases (30 eyes)</p></td><td align="left">-CC flow area</td><td align="left"><p>-Patients with diabetes showed a slight increase in CC flow area compared to controls (mean area of 22.6&#x02009;&#x000b1;&#x02009;3.9 mm2 vs. 22.3&#x02009;&#x000b1;&#x02009;4.6 mm2, <italic>p</italic>&#x02009;=&#x02009;0.017).</p><p>-There was a positive correlation between fasting blood glucose levels and CC flow area (<italic>p</italic>&#x02009;=&#x02009;0.034).</p></td></tr><tr><td align="left">Loria et al. 2021 [<xref ref-type="bibr" rid="CR15">15</xref>]</td><td align="left">7</td><td align="left">SS-OCTA</td><td align="left"><p>-HC: 17</p><p>-NDR: 30</p><p>-Minimal NPDR:22</p><p>-Moderate NPDR:30</p><p>-Severe NPDR:16</p><p>-PDR: 5</p></td><td align="left">-CC Flow void area</td><td align="left">-There was a significant positive correlation between CC flow void area and DR stage. Furthermore, FVA-CC was significantly higher in diabetic patients without DR compared to healthy individuals (<italic>P</italic>&#x02009;=&#x02009;0.008).</td></tr><tr><td align="left">Ro-Mase et al. 2020[<xref ref-type="bibr" rid="CR51">51</xref>]</td><td align="left">8</td><td align="left">SD-OCT</td><td align="left"><p>-T2DM: 26 cases including:</p><p>NDR: 4,</p><p>NPDR:12,</p><p>and PDR:10</p><p>-HC: 13</p></td><td align="left"><p>-CC FD</p><p>-Microperimetry: Retinal sensitivity</p><p>-AO: HPi</p></td><td align="left"><p>-In patients with NPDR and PDR, there was a significant correlation between foveal and CC FD and retinal sensitivity (fovea, <italic>r</italic> = -0.58; <italic>P</italic>&#x02009;=&#x02009;0.046 and <italic>r</italic> = -0.82; <italic>P</italic>&#x02009;=&#x02009;0.003; parafovea, <italic>r</italic> = -0.59; <italic>P</italic>&#x02009;=&#x02009;0.044 and <italic>r</italic> = -0.72; <italic>P</italic>&#x02009;=&#x02009;0.019, respectively), but not in control and NDR groups.</p><p>-No significant differences were found in HPi across all groups.</p></td></tr><tr><td align="left">Dai et al. 2020 [<xref ref-type="bibr" rid="CR1">1</xref>]</td><td align="left">8</td><td align="left">SS-OCTA</td><td align="left"><p>-DM: 45 with DR</p><p>-HC: 27</p><p>-Extreme axial lengths of <italic>&#x0003e;</italic>&#x02009;25.2&#x000a0;mm or <italic>&#x0003c;</italic>&#x02009;23.2&#x000a0;mm were excluded</p></td><td align="left">-CC FD (5-mm from 6*6&#x000a0;mm scans)</td><td align="left"><p>- Compared to control eyes, diabetic eyes had a significantly higher CC FD% (12.34&#x02009;&#x000b1;&#x02009;4.14% vs. 8.82&#x02009;&#x000b1;&#x02009;2.61%, <italic>P</italic>&#x02009;&#x0003c;&#x02009;0.001) and larger mean CC FD size (2151.3&#x02009;&#x000b1;&#x02009;650.8&#x000b5;m2 vs. 1574.4&#x02009;&#x000b1;&#x02009;255.0 &#x000b5;m2, <italic>P</italic>&#x02009;&#x0003c;&#x02009;0.001), with both values being 1.4-fold greater on average.</p><p>- There was no significant difference in CC FD% or mean CC FD size between eyes with NPDR and those with PDR (<italic>P</italic>&#x02009;=&#x02009;1.000 and <italic>P</italic>&#x02009;=&#x02009;1.000, respectively).</p></td></tr><tr><td align="left">Saif et al. 2020 [<xref ref-type="bibr" rid="CR9">9</xref>]</td><td align="left">7</td><td align="left">SS-OCTA</td><td align="left"><p>-HC: 16 eyes</p><p>-NDR: 16 eyes</p><p>-NPDR: 16 eyes</p><p>-PDR: 16 eyes</p></td><td align="left">-Choroidal vascular density</td><td align="left">-There was a decrease in choroidal vascular density in diabetic patients compared to healthy control group.</td></tr><tr><td align="left">Ashraf et al. 2020[<xref ref-type="bibr" rid="CR35">35</xref>]</td><td align="left">N/A</td><td align="left">3*3&#x000a0;mm macular scan</td><td align="left"><p>-225 cases Type 1 or Type 2 DM (352 eyes), including:</p><p>Mild NPDR:183, Moderate NPDR:71,</p><p>Sever NPDR or PDR:98</p></td><td align="left">-CC FD</td><td align="left"><p>Among eyes without predominantly peripheral lesions, the mean CC flow density decreased with increasing DR severity (mild NPDR, 69.7% [6.2%]; moderate NPDR, 67.6% [5.6%]; severe NPDR or PDR, 67.1% [5.6%]; <italic>P</italic>&#x02009;=&#x02009;0.01).</p><p>-However, in eyes with predominantly peripheral lesions, the mean CC flow density did not appear to change with increasing DR severity (mild NPDR, 67.1% [5.6%]; moderate NPDR, 69.3% [4.6%]; severe NPDR or PDR, 68.3% [5.6%]; <italic>P</italic>&#x02009;=&#x02009;0.49).</p></td></tr><tr><td align="left">Dai et al. 2020 [<xref ref-type="bibr" rid="CR6">6</xref>]</td><td align="left">8</td><td align="left">SS-OCTA</td><td align="left"><p>-NDR: 16 cases (16 eyes)</p><p>-HC: 16</p></td><td align="left"><p>-CC FD%</p><p>-CC FD size</p></td><td align="left"><p>-In diabetic eyes, compared to controls, there were significant increases in mean FD% and mean FD sizes in the central 1.0-mm disk (<italic>P</italic>&#x02009;=&#x02009;0.011 and <italic>P</italic>&#x02009;=&#x02009;0.017), the central 1.5-mm rim (<italic>P</italic>&#x02009;=&#x02009;0.003 and <italic>P</italic>&#x02009;=&#x02009;0.009), the central 2.5-mm rim (<italic>P</italic>&#x02009;=&#x02009;0.018 and <italic>P</italic>&#x02009;=&#x02009;0.020), and the entire 5.0-mm disk (<italic>P</italic>&#x02009;=&#x02009;0.009 and <italic>P</italic>&#x02009;=&#x02009;0.008).</p><p>-There were no significant differences in any retinal vessel quantitative parameters between the two groups (all <italic>P</italic>&#x02009;&#x0003e;&#x02009;0.05).</p></td></tr><tr><td align="left">Gendelman et al. 2020 [<xref ref-type="bibr" rid="CR7">7</xref>]</td><td align="left">N/A</td><td align="left">SS-OCTA</td><td align="left"><p>-90 DM cases (160 eyes), including:</p><p>NDR: 33,</p><p>Mild NPDR:17,</p><p>Moderate NPDR: 8, Severe NPDR: 10, and</p><p>PDR:22</p></td><td align="left">-CC FD</td><td align="left"><p>-Age and severity of DR were significantly and positively associated with FD% in all studied regions, with a greater effect observed in the two centermost regions.</p><p>-The increase in FD percentage per year of age varied by region: 0.12 for the inner (<italic>p</italic>&#x02009;&#x0003c;&#x02009;0.001), 0.09 for the middle (<italic>p</italic>&#x02009;&#x0003c;&#x02009;0.001), 0.05 for the outer (<italic>p</italic>&#x02009;&#x0003c;&#x02009;0.001), and 0.06 for the full-field (<italic>p</italic>&#x02009;&#x0003c;&#x02009;0.001).</p><p>-The increase in FD percentage per increase in DR severity stage also varied by region: 0.65 for the inner (<italic>p</italic>&#x02009;&#x0003c;&#x02009;0.0087), 0.56 for the middle (<italic>p</italic>&#x02009;&#x0003c;&#x02009;0.0012), 0.33 for the outer (<italic>p</italic>&#x02009;&#x0003c;&#x02009;0.045), and 0.36 for the full-field (<italic>p</italic>&#x02009;&#x0003c;&#x02009;0.018).</p></td></tr><tr><td align="left">Lupidi et al. 2020 [<xref ref-type="bibr" rid="CR37">37</xref>]</td><td align="left">7</td><td align="left"/><td align="left"><p>-29 diabetic patients with Level 20 DR severity score</p><p>-HC: 20</p></td><td align="left"><p>-CC vascular perfusion density</p><p>-SCP and DCP vascular perfusion density</p></td><td align="left"><p>In diabetic patients, vascular perfusion density values were significantly lower in the DCP (25.1% vs. 26.5%; <italic>p</italic>&#x02009;=&#x02009;0.04) and CC (71.2% vs. 86.6%; <italic>p</italic>&#x02009;=&#x02009;0.0001) compared to controls.</p><p>-A negative linear correlation was found between CC vascular perfusion density and DCP vascular perfusion density in diabetic patients, while a positive linear correlation was observed between the same parameters in controls.</p></td></tr><tr><td align="left">Borrelli et al. 2020 [<xref ref-type="bibr" rid="CR54">54</xref>]</td><td align="left">7</td><td align="left"/><td align="left"><p>-NPDR: 30</p><p>-HC: 30</p></td><td align="left"><p>-EZ normalized reflectivity</p><p>-CC perfusion density</p></td><td align="left"><p>-The NPDR group had impaired perfusion in both retinal and choroidal vasculature, and a lower &#x0201c;normalized&#x0201d; reflectivity compared to controls (0.73&#x02009;&#x000b1;&#x02009;0.19 vs. 0.96&#x02009;&#x000b1;&#x02009;0.25, <italic>P</italic>&#x02009;&#x0003c;&#x02009;0.0001).</p><p>-Multiple regression analysis showed a significant direct association between EZ &#x0201c;normalized&#x0201d; reflectivity and CC perfusion density in NPDR patients (<italic>P</italic>&#x02009;=&#x02009;0.025) but not in controls (<italic>P</italic>&#x02009;=&#x02009;0.476).</p></td></tr><tr><td align="left">Forte et al. 2020 [<xref ref-type="bibr" rid="CR14">14</xref>]</td><td align="left">7</td><td align="left">SS-OCTA</td><td align="left"><p>-T1DM NDR:</p><p>17</p><p>-T2DM NDR: 17</p><p>-23 HC</p></td><td align="left">-CC voids</td><td align="left">-There was a higher frequency of CC voids in both DM Type 1 and DM Type 2 compared to controls (<italic>P</italic>&#x02009;=&#x02009;0.003 and <italic>P</italic>&#x02009;&#x0003c;&#x02009;0.001, respectively).</td></tr><tr><td align="left">Sacconi et al. 2019 [<xref ref-type="bibr" rid="CR23">23</xref>]</td><td align="left">9</td><td align="left">SD-OCTA</td><td align="left"><p>-T1DM NDR: 34 cases (34 eyes)</p><p>-HC: 27</p></td><td align="left">-CC perfusion density</td><td align="left">-OCTA showed lower deep capillary plexus perfusion density in diabetics than the control group, but no significant differences were found in other retinal/choriocapillaris plexuses or foveal avascular zone area.</td></tr><tr><td align="left">Mastropasqua et al. 2019 [<xref ref-type="bibr" rid="CR46">46</xref>]</td><td align="left">8</td><td align="left">SS-OCTA</td><td align="left"><p>-94 cases (95 eyes), including:</p><p>NDR: 25,</p><p>Mild NPDR: 23,</p><p>Mod/sever DR: 26, and PDR: 20</p><p>-HC: 25</p></td><td align="left">-CC, SCP and DCP perfusion density (central vs. peripheral)</td><td align="left">-The prediction of disease worsening had excellent specificity and good sensitivity, particularly in the central and temporal sectors across all plexuses.</td></tr><tr><td align="left">Yang et al. 2019 [<xref ref-type="bibr" rid="CR4">4</xref>]</td><td align="left">8</td><td align="left"/><td align="left"><p>-HC: 43</p><p>-NDR: 56</p><p>-Mild DR: 43</p><p>-Moderate DR: 54</p><p>-Severe DR: 38</p><p>-PDR: 48</p></td><td align="left">-CC flow density</td><td align="left"><p>-As DR progressed, there was a downward trend in CC flow density in the CC layer.</p><p>-Significant differences were found between mild NPDR and moderate NPDR and between severe NPDR and PDR in the comparison of CFD in the CC layer using both 3-mm and 6-mm scan patterns (<italic>P</italic>&#x02009;=&#x02009;0.003, <italic>P</italic>&#x02009;=&#x02009;0.001).</p></td></tr><tr><td align="left">Yang et al. 2019 [<xref ref-type="bibr" rid="CR38">38</xref>]</td><td align="left">8</td><td align="left"/><td align="left"><p>-HC: 40</p><p>-Mild DR: 40</p><p>-Moderate DR: 40</p><p>-Severe DR: 40</p><p>-PDR: 40</p></td><td align="left">-CC vascular density</td><td align="left"><p>-As DR severity increased, there was a reduction in macular perfusion in the SCP, DCP, and CC.</p><p>-Vessel density in the DCP was found to be a better indicator of DR severity, with an area under the curve, sensitivity, and specificity of 0.967, 92.5%, and 93.1%, respectively, compared to vessel density in the SCP and CC.</p></td></tr><tr><td align="left">Conti et al., 2019 [<xref ref-type="bibr" rid="CR26">26</xref>]</td><td align="left">7</td><td align="left">SD-OCTA</td><td align="left"><p>-HC: 37 eyes</p><p>-NDR: 31 eyes</p><p>-NPDR: 41 eyes</p><p>-PDR: 27 eyes</p></td><td align="left">-CC capillary perfusion density</td><td align="left"><p>-Eyes affected by both NPDR and PDR exhibited a significant reduction in choriocapillaris capillary perfusion density when compared to controls. In contrast, diabetic eyes without retinopathy did not display a noteworthy change.</p><p>-The whole-image capillary perfusion density of the CC declined by 8.3% in NPDR eyes (<italic>p</italic>&#x02009;&#x0003c;&#x02009;0.01) and by 7.1% in PDR eyes (<italic>p</italic>&#x02009;&#x0003c;&#x02009;0.01). Additionally, parafoveal capillary perfusion density in the choriocapillaris showed an 8.9% decrease in NPDR eyes (<italic>p</italic>&#x02009;&#x0003c;&#x02009;0.01) and an 8.2% decrease in PDR eyes (<italic>p</italic>&#x02009;&#x0003c;&#x02009;0.01).</p></td></tr><tr><td align="left">Rodrigues et al. 2019 [<xref ref-type="bibr" rid="CR36">36</xref>]</td><td align="left">N/A</td><td align="left">SD-OCT</td><td align="left"><p>-NPDR:</p><p>56 cases (101 eyes)</p></td><td align="left">-CC vascular density</td><td align="left"><p>-Univariate analysis revealed that higher ETDRS level was associated with several OCTA parameters, including parafoveal SCP density (OR&#x02009;=&#x02009;0.87, 95% CI 0.76&#x02013;0.99, <italic>p</italic>&#x02009;=&#x02009;0.039), parafoveal DCP density (OR&#x02009;=&#x02009;0.79, 95% CI 0.72&#x02013;0.87, <italic>p</italic>&#x02009;&#x0003c;&#x02009;0.001), and CC density (OR&#x02009;=&#x02009;0.89, 95% CI 0.80&#x02013;0.99, <italic>p</italic>&#x02009;=&#x02009;0.036).</p><p>-However, after adjusting for relevant clinical features, only parafoveal vessel density in the DCP remained a significant predictor of NPDR ETDRS level (OR&#x02009;=&#x02009;0.54, 95% CI 0.32&#x02013;0.92, <italic>p</italic>&#x02009;=&#x02009;0.024).</p></td></tr><tr><td align="left">Li et al. 2019 [<xref ref-type="bibr" rid="CR48">48</xref>]</td><td align="left">8</td><td align="left">SD-OCTA</td><td align="left"><p>-T-2DM: 97 patients (NDR to PDR)</p><p>-HC: 48</p></td><td align="left"><p>-Foveal and parafoveal CC vascular density</p><p>-Foveal flow area in CC plexus</p></td><td align="left"><p>-Compared to controls, diabetic patients had lower flow area in CC plexus and vascular density in all three layers.</p><p>-In the NDR group, foveal flow area in CC plexus decreased significantly compared to controls. In mild NPDR, parafoveal VD decreased significantly in all three layers compared to NDR, particularly in the temporal and nasal areas. In moderate NPDR, vascular density reduction extended to the inferior area in SCP and DCP compared to mild NPDR. In severe NPDR, there were progressive losses of vascular density in all layers compared to moderate NPDR. In PDR, the superior vascular density in SCP increased significantly compared to severe NPDR.</p></td></tr><tr><td align="left">Li et al. 2018 [<xref ref-type="bibr" rid="CR18">18</xref>]</td><td align="left">7</td><td align="left">SD-OCTA</td><td align="left"><p>-T2DM NDR: 42 cases (42 eyes)</p><p>-HC: 40</p></td><td align="left">-CC flow area</td><td align="left">-Reduced CC flow area was significantly more obvious in the NDR subjects than in the control subjects (1.94&#x02009;&#x000b1;&#x02009;0.28 versus 2.05&#x02009;&#x000b1;&#x02009;0.11 mm2, <italic>p</italic>&#x02009;=&#x02009;0.02).</td></tr><tr><td align="left">Cao et al. 2018 [<xref ref-type="bibr" rid="CR56">56</xref>]</td><td align="left">7</td><td align="left">SD-OCTA</td><td align="left"><p>-T2DM NDR: 71</p><p>-HC: 67</p></td><td align="left">-CC vessel density</td><td align="left">-NDR group showed a significant reduction in average vessel density of SCP, DCP, and CC (<italic>p</italic>&#x02009;&#x0003c;&#x02009;0.001, <italic>p</italic>&#x02009;&#x0003c;&#x02009;0.001, and <italic>p</italic>&#x02009;=&#x02009;0.006, respectively).</td></tr><tr><td align="left">Carnevali et al. 2017 [<xref ref-type="bibr" rid="CR24">24</xref>]</td><td align="left">7</td><td align="left">SD-OCTA</td><td align="left"><p>-T1DM NDR; 25 cases</p><p>-HC: 25</p></td><td align="left">-CC vessel density</td><td align="left"><p>-Comparison of the DCP between diabetic and control eyes showed a significant decrease in vessel density in the diabetic group [0.464&#x02009;&#x000b1;&#x02009;0.016 vs. 0.477&#x02009;&#x000b1;&#x02009;0.014, respectively (<italic>p</italic>&#x02009;=&#x02009;0.005)].</p><p>-However, no significant differences were found in vessel density in the all-retina plexus, SCP, or choriocapillaris.</p></td></tr><tr><td align="left">Dimitrova et al. 2017 [<xref ref-type="bibr" rid="CR25">25</xref>]</td><td align="left">9</td><td align="left">SD-OCTA</td><td align="left"><p>-DM NDR: 29</p><p>-HC: 32</p></td><td align="left">-CC vessel density</td><td align="left"><p>-Compared to control subjects, NDR patients had decreased vessel densities in both superficial and deep retina [44.35% &#x000b1; 13.31% and 31.03% &#x000b1; 16.33% vs. 51.39% &#x000b1; 13.05%, <italic>P</italic>&#x02009;=&#x02009;0.04; and 41.53% &#x000b1; 14.08% vs. control, <italic>P</italic>&#x02009;&#x0003c;&#x02009;0.01, respectively].</p><p>-They also observed a tendency towards decrease in CC vessel density in diabetic eyes without DR compared to healthy subjects; however, the difference did not reach statistical significance.</p><p>-There was a significant negative correlation between CC density and diastolic blood pressure in the NDR group (<italic>r</italic>&#x02009;=&#x02009;&#x02212;&#x02009;0.42, <italic>P</italic>&#x02009;=&#x02009;0.02).</p></td></tr><tr><td align="left">Choi et al. 2017 [<xref ref-type="bibr" rid="CR5">5</xref>]</td><td align="left">8</td><td align="left">SS-OCTA</td><td align="left"><p>-HC: 32 cases (63 eyes)</p><p>-PDR: 7 (9 eyes)</p><p>-NPDR: 16 (29 eyes)</p><p>-DM NDR: 28 (51 eyes)</p></td><td align="left">-CC flow impairment</td><td align="left">-CC flow impairment was observed in patients with either PDR or NPDR. Furthermore, CC flow impairment was found in 24 out of 51 diabetic eyes with no DR.</td></tr></tbody></table><table-wrap-foot><p>AUC, area under the curve; BCVA, best-corrected visual acuity; CC, choriocapillaris; CD, cone density; DCP, deep capillary plexus; DM, diabetes mellitus; DME, diabetic macular edema; DR, diabetic retinopathy; ERG, electroretinography; ETDRS, Early Treatment Diabetic Retinopathy Study; EZ, ellipsoid zone; FD, flow deficit; FDa, flow deficit area; FDn, flow deficit number; HbA1c, hemoglobin A1c; HC, healthy controls; HPi, heterogeneity packing index; LDi, linear dispersion index; logMAR, logarithm of the minimum angle of resolution; MA, microalbuminuria; mfERG, multifocal electroretinography; N/A, not applicable; NDR, no diabetic retinopathy; NPDR, non-proliferative diabetic retinopathy; OCTA, optical coherence tomography angiography; OR, odds ratio; PDR, proliferative diabetic retinopathy; RAD, response amplitude density; RPE, retinal pigment epithelium; SCP, superficial capillary plexus; SD, standard deviation; SD-OCTA, spectral-domain optical coherence tomography angiography; SS-OCTA, swept-source optical coherence tomography angiography; T1DM, type 1 diabetes mellitus; T2DM, type 2 diabetes mellitus</p></table-wrap-foot></table-wrap>
</p><p id="Par21">E-Tables&#x000a0;<xref rid="MOESM1" ref-type="media">1</xref> and <xref rid="MOESM1" ref-type="media">2</xref> provide a quality assessment of cohort and case-control studies based on the Newcastle-Ottawa Scale criteria. In the subsequent sections, we categorize and discuss the key findings of these papers.</p><sec id="Sec4"><title>The pros and cons of OCTA in the assessment of choroidal microangiopathy</title><p id="Par22">OCTA offers a three-dimensional visualization of the retinal and choroidal microvasculature at multiple depths [<xref ref-type="bibr" rid="CR5">5</xref>]. It facilitates detailed examination of the foveal avascular zone&#x02019;s shape and provides assessment of retinal lesions, including areas of nonperfusion, microaneurysms, and neovascularization [<xref ref-type="bibr" rid="CR13">13</xref>]. OCTA also enables the visualization of choroidal lesions (such as &#x0201c;medusa,&#x0201d; &#x0201c;sea fan,&#x0201d; &#x0201c;glomerular,&#x0201d; and &#x0201c;dead tree&#x0201d; patterns) and choroidal vessel structures [<xref ref-type="bibr" rid="CR13">13</xref>]. A significant advantage of OCTA is its ability to perform rapid, high-resolution qualitative and quantitative evaluations of retinal and choroidal circulation at different depths and layers [<xref ref-type="bibr" rid="CR5">5</xref>, <xref ref-type="bibr" rid="CR13">13</xref>]. Additionally, the non-invasive nature of OCTA allows for repeated scans during the same visit or subsequent visits, and it can simultaneously provide structural data during OCT imaging [<xref ref-type="bibr" rid="CR5">5</xref>].</p><p id="Par23">It is important to note that swept-source OCTA (SS-OCTA) is more reliable than spectral-domain OCTA (SD-OCTA) for visualizing and evaluating choroidal vessels [<xref ref-type="bibr" rid="CR6">6</xref>]. This superiority is due to the longer laser wavelength used in SS-OCTA, which experiences less scattering by the retinal pigment epithelium (RPE), whereas the shorter wavelength of SD-OCTA is more affected by RPE scattering [<xref ref-type="bibr" rid="CR6">6</xref>].</p><p id="Par24">OCTA has certain limitations; it cannot detect blood-retinal barrier breakdown or vascular leakage, which are visible with Fluorescein angiography [<xref ref-type="bibr" rid="CR13">13</xref>]. Other challenges include accurate segmentation of the choriocapillaris, the elimination of projection artifacts, and the lack of standardized terminology for consistent data interpretation [<xref ref-type="bibr" rid="CR13">13</xref>]. Another drawback is OCTA&#x02019;s reduced ability to visualize intervascular spaces within the choriocapillaris [<xref ref-type="bibr" rid="CR13">13</xref>]. This issue arises because the distance between individual choriocapillaris (5&#x02013;20&#x000a0;&#x003bc;m) is smaller than the lateral resolution of the OCT system (15&#x02013;20&#x000a0;&#x003bc;m), making it difficult to clearly resolve individual choriocapillaris [<xref ref-type="bibr" rid="CR6">6</xref>]. To address this, researchers use markers such as the percentage and size of flow deficits to evaluate choriocapillaris perfusion in different macular regions [<xref ref-type="bibr" rid="CR6">6</xref>]. A flow deficit at the choriocapillaris level is detected when blood flow falls below the detectable threshold of OCTA images [<xref ref-type="bibr" rid="CR1">1</xref>].</p></sec><sec id="Sec5"><title>Comparison of OCTA findings in the choriocapillaris of diabetic eyes without diabetic retinopathy versus healthy individuals</title><p id="Par25">Findings from various studies indicate a significant decrease in choroidal perfusion parameters in diabetic patients without diabetic retinopathy (NDR) compared to healthy individuals [<xref ref-type="bibr" rid="CR6">6</xref>, <xref ref-type="bibr" rid="CR14">14</xref>&#x02013;<xref ref-type="bibr" rid="CR19">19</xref>]. For example, Forte et al. observed a higher prevalence of choriocapillaris flow voids in the NDR group with both type 1 and type 2 diabetes compared to healthy subjects (<italic>P</italic>&#x02009;=&#x02009;0.003 and <italic>P</italic>&#x02009;&#x0003c;&#x02009;0.001, respectively), with no statistically significant difference between the two diabetic subgroups (<italic>P</italic>&#x02009;=&#x02009;0.8) [<xref ref-type="bibr" rid="CR14">14</xref>]. Similarly, Dai et al. reported a significant increase in the percentage and average size of choriocapillaris flow deficits across various regions, including the central 1.0-mm zone (<italic>P</italic>&#x02009;=&#x02009;0.011 and <italic>P</italic>&#x02009;=&#x02009;0.017), the central 1.5-mm rim (<italic>P</italic>&#x02009;=&#x02009;0.003 and <italic>P</italic>&#x02009;=&#x02009;0.009), the central 2.5-mm rim (<italic>P</italic>&#x02009;=&#x02009;0.018 and <italic>P</italic>&#x02009;=&#x02009;0.020), and the entire 5.0-mm zone (<italic>P</italic>&#x02009;=&#x02009;0.009 and <italic>P</italic>&#x02009;=&#x02009;0.008) in NDR eyes compared to controls [<xref ref-type="bibr" rid="CR6">6</xref>]. Additionally, Loria et al. found that diabetic patients without DR had a significantly higher choriocapillaris flow void area than healthy individuals (<italic>P</italic>&#x02009;=&#x02009;0.008) [<xref ref-type="bibr" rid="CR15">15</xref>]. Furthermore, Zlatanovi&#x00107; et al. demonstrated a significant reduction in choriocapillaris flow area and vascular density in the NDR group compared to healthy subjects (<italic>P</italic>&#x02009;&#x0003c;&#x02009;0.001 for both) [<xref ref-type="bibr" rid="CR16">16</xref>].</p><p id="Par26">Another choroidal perfusion parameter, the choroid vascularity index (CVI), is defined as the proportion of the choroidal vascular luminal area to the total choroid area. Previous studies have shown a decrease in CVI in diabetic patients compared to healthy controls [<xref ref-type="bibr" rid="CR20">20</xref>, <xref ref-type="bibr" rid="CR22">22</xref>]. For example, Xu et al. reported a significant decrease in CVI in the choriocapillaris of patients with pre-DR and early-stage DR due to type 2 diabetes, particularly in the more peripheral 9&#x02013;12&#x000a0;mm area (<italic>P</italic>&#x02009;&#x0003c;&#x02009;0.05) [<xref ref-type="bibr" rid="CR21">21</xref>]. They also observed a significant negative correlation between the duration of diabetes and CVI, with the strongest correlation in the 9&#x02013;12&#x000a0;mm area [<xref ref-type="bibr" rid="CR21">21</xref>]. Aksoy et al. similarly reported a negative correlation between CVI and diabetes duration in NDR eyes (coefficient: -0.416, <italic>P</italic>&#x02009;=&#x02009;0.006), suggesting progressive subclinical dysfunction in the choroid of diabetic patients [<xref ref-type="bibr" rid="CR22">22</xref>].</p><p id="Par27">Tan et al. found that choriocapillaris parameters were more effective in distinguishing NDR from healthy controls compared to retinal parameters (area under the curve of 0.954 vs. 0.821, <italic>P</italic>&#x02009;=&#x02009;0.006) [<xref ref-type="bibr" rid="CR20">20</xref>]. However, some authors suggest that alterations in perfusion within the deep capillary plexus (DCP) may serve as a superior marker for early diabetic microangiopathy compared to changes in the choriocapillaris [<xref ref-type="bibr" rid="CR23">23</xref>]. Sacconi et al. found reduced perfusion density in the DCP layer in the NDR group compared to controls, with no significant differences in other perfusion density measurements in the choriocapillaris or superficial capillary plexus (SCP) [<xref ref-type="bibr" rid="CR23">23</xref>]. Similarly, Carnevali et al. reported a significant reduction in vessel density in the DCP in NDR eyes compared to controls (<italic>P</italic>&#x02009;=&#x02009;0.005), while no significant differences were observed in the all-retina plexus, SCP, or choriocapillaris between the groups [<xref ref-type="bibr" rid="CR24">24</xref>].</p><p id="Par28">While reduced choriocapillaris flow may serve as an imaging marker for detecting early microvascular ischemia in patients with NDR, this reduction in choroid perfusion does not always achieve statistical significance [<xref ref-type="bibr" rid="CR25">25</xref>]. For instance, Dimitrova et al. reported that although there was a trend toward decreased choriocapillaris vessel density in NDR eyes compared to healthy subjects, this difference did not reach statistical significance [<xref ref-type="bibr" rid="CR25">25</xref>].</p><p id="Par29">On the other hand, some studies debated the role of OCTA in detecting preclinical alterations in diabetic choroidal vasculature [<xref ref-type="bibr" rid="CR23">23</xref>, <xref ref-type="bibr" rid="CR24">24</xref>, <xref ref-type="bibr" rid="CR26">26</xref>, <xref ref-type="bibr" rid="CR27">27</xref>]. For instance, Conti et al. found no significant difference in choriocapillaris capillary perfusion density between the NDR group and healthy controls [<xref ref-type="bibr" rid="CR26">26</xref>]. Additionally, Agra et al. reported a marginal increase in choriocapillaris flow area among NDR patients compared to controls (<italic>P</italic>&#x02009;=&#x02009;0.017), suggesting that OCTA may not be the most suitable tool for detecting preclinical changes in diabetic patients [<xref ref-type="bibr" rid="CR27">27</xref>]. They further emphasized that OCTA should not replace clinical examinations [<xref ref-type="bibr" rid="CR27">27</xref>].</p></sec><sec id="Sec6"><title>Association between DR stage and choriocapillaris OCTA indices</title><p id="Par30">Several studies suggest that diabetes-associated alterations in the choriocapillaris detected by OCTA correlate with the stage of diabetic retinopathy (DR) [<xref ref-type="bibr" rid="CR15">15</xref>, <xref ref-type="bibr" rid="CR28">28</xref>&#x02013;<xref ref-type="bibr" rid="CR31">31</xref>]. For example, Loria et al. found a significant positive correlation between the choriocapillaris flow void area and the stage of DR (<italic>P</italic>&#x02009;&#x0003c;&#x02009;0.0001) [<xref ref-type="bibr" rid="CR15">15</xref>]. Fragiotta et al. reported a continuous increase in the percentage of choriocapillaris flow deficit over time in eyes with mild non-proliferative DR (NPDR) (<italic>P</italic>&#x02009;&#x0003c;&#x02009;0.01) [<xref ref-type="bibr" rid="CR28">28</xref>]. Thaker et al. also noted a positive correlation between the number of choroidal flow voids and the severity of NPDR (<italic>P</italic>&#x02009;&#x0003c;&#x02009;0.0001) [<xref ref-type="bibr" rid="CR29">29</xref>]. Gendelman et al. found a significant increase in choriocapillaris flow deficit across inner, middle, outer, and full-field macular regions with worsening DR (<italic>P</italic>&#x02009;&#x0003c;&#x02009;0.0087, <italic>P</italic>&#x02009;&#x0003c;&#x02009;0.0012, <italic>P</italic>&#x02009;&#x0003c;&#x02009;0.045, and <italic>P</italic>&#x02009;&#x0003c;&#x02009;0.018, respectively) [<xref ref-type="bibr" rid="CR7">7</xref>].</p><p id="Par31">Similarly, Dodo et al. observed that, as DR severity increased from moderate NPDR to severe NPDR and proliferative DR (PDR), the area of choriocapillaris flow void within the central subfield gradually increased (<italic>P</italic>&#x02009;=&#x02009;0.032, <italic>P</italic>&#x02009;=&#x02009;0.009, and <italic>P</italic>&#x02009;=&#x02009;0.002, respectively) [<xref ref-type="bibr" rid="CR32">32</xref>]. They proposed two explanations for this correlation: first, that outer retinal ischemia may result from disruption in choroidal blood flow, potentially leading to increased vascular endothelial growth factor expression and DR progression [<xref ref-type="bibr" rid="CR32">32</xref>, <xref ref-type="bibr" rid="CR33">33</xref>]; and second, that capillary dropout in the inner choroid might result from diabetes-induced damage to the RPE and subsequent disturbance in choriocapillaris maintenance [<xref ref-type="bibr" rid="CR32">32</xref>, <xref ref-type="bibr" rid="CR34">34</xref>].</p><p id="Par32">Ashraf et al. found that choriocapillaris flow density decreases with increasing DR severity in patients without predominantly peripheral lesions [<xref ref-type="bibr" rid="CR35">35</xref>]. However, this association was not observed in patients with predominantly peripheral lesions [<xref ref-type="bibr" rid="CR35">35</xref>]. They concluded that nonperfusion in diabetic eyes likely exists along a spectrum, ranging from central to peripheral nonperfusion predominance [<xref ref-type="bibr" rid="CR35">35</xref>].</p><p id="Par33">Rodrigues et al. reported a correlation between higher Early Treatment Diabetic Retinopathy Study (ETDRS) levels and various OCTA parameters, including parafoveal SCP density (<italic>P</italic>&#x02009;=&#x02009;0.039), parafoveal DCP density (<italic>P</italic>&#x02009;&#x0003c;&#x02009;0.001), and choriocapillaris density (<italic>P</italic>&#x02009;=&#x02009;0.036) in patients with NPDR [<xref ref-type="bibr" rid="CR36">36</xref>]. However, after adjusting for pertinent clinical factors, only parafoveal vessel density in the DCP remained a significant predictor of ETDRS level (<italic>P</italic>&#x02009;=&#x02009;0.024) [<xref ref-type="bibr" rid="CR36">36</xref>]. Therefore, they concluded that parafoveal vessel density in the DCP is the most robust parameter associated with ETDRS level [<xref ref-type="bibr" rid="CR36">36</xref>].</p><p id="Par34">Lupidi et al. demonstrated that diabetic patients with a DR severity score of level 20 exhibited significantly lower vascular perfusion density values in both DCP (25.1% vs. 26.5%; <italic>P</italic>&#x02009;=&#x02009;0.04) and the choriocapillaris (71.2% vs. 86.6%; <italic>P</italic>&#x02009;=&#x02009;0.0001) compared to controls [<xref ref-type="bibr" rid="CR37">37</xref>]. An inverse linear correlation was found between these two parameters in diabetic patients, in contrast to a positive linear correlation observed in controls [<xref ref-type="bibr" rid="CR37">37</xref>]. This suggests that the retinal and choroidal vascular networks, while distinct, may be functionally interconnected, and variations in perfusion levels could represent a shared compensatory response to ischemic injury [<xref ref-type="bibr" rid="CR37">37</xref>].</p><p id="Par35">Yang et al. also observed a consistent decrease in macular perfusion across the SCP, DCP, and choriocapillaris with increasing DR severity [<xref ref-type="bibr" rid="CR38">38</xref>]. However, they found that vessel density in the DCP serves as a superior indicator of DR severity, with an area under the curve of 0.967, sensitivity of 92.5%, and specificity of 93.1% [<xref ref-type="bibr" rid="CR38">38</xref>]. Ryu et al. similarly reported associations between DR severity and all retinal and choroidal microvascular indices, but highlighted that changes were more pronounced in the retinal capillary plexuses compared to the choriocapillaris [<xref ref-type="bibr" rid="CR39">39</xref>].</p><p id="Par36">Some studies suggest that reduced choroidal perfusion may increase the risk of developing PDR in patients with NPDR [<xref ref-type="bibr" rid="CR40">40</xref>, <xref ref-type="bibr" rid="CR41">41</xref>]. For instance, Wang et al. reported a 1.69-fold higher risk of PDR development for each 1% increase in baseline choriocapillaris flow deficit percentage after following patients with type 2 diabetes for one year [<xref ref-type="bibr" rid="CR40">40</xref>]. Liu et al. also found a lower choroidal perfusion rate in the PDR group compared to the NPDR group [<xref ref-type="bibr" rid="CR41">41</xref>]. Ra et al. reported that patients with PDR exhibited lower choriocapillaris vascular density than those with NPDR (<italic>P</italic>&#x02009;&#x0003c;&#x02009;0.05) [<xref ref-type="bibr" rid="CR42">42</xref>]. In contrast, Ghassemi et al. found no significant change in choriocapillaris vessel density from the NPDR to PDR stage [<xref ref-type="bibr" rid="CR43">43</xref>].</p><p id="Par37">Some previous studies also suggest that an increase in choriocapillaris flow deficit may elevate the risk of developing diabetic macular edema in patients with type 2 diabetes [<xref ref-type="bibr" rid="CR44">44</xref>, <xref ref-type="bibr" rid="CR45">45</xref>]. Yang et al. found significant differences in choriocapillaris flow density between patients with and without diabetic macular edema (<italic>P</italic>&#x02009;&#x0003c;&#x02009;0.001) [<xref ref-type="bibr" rid="CR4">4</xref>].</p><p id="Par38">While many studies support a correlation between the stage of DR and alterations in choriocapillaris flow with high specificity and good sensitivity [<xref ref-type="bibr" rid="CR46">46</xref>], others argue that deterioration of choriocapillaris flow does not always align with DR severity [<xref ref-type="bibr" rid="CR5">5</xref>]. For example, Choi et al. reported no clear correlation between the presence or severity of retinal microangiopathy and choriocapillaris flow impairment in most diabetic eyes [<xref ref-type="bibr" rid="CR5">5</xref>]. In addition, Yang et al. found significant differences in choriocapillaris flow density between mild NPDR and moderate NPDR and between severe NPDR and PDR on both 3-mm (<italic>P</italic>&#x02009;=&#x02009;0.001 and <italic>P</italic>&#x02009;=&#x02009;0.003, respectively) and 6-mm scan patterns (<italic>P</italic>&#x02009;&#x0003c;&#x02009;0.001 and <italic>P</italic>&#x02009;=&#x02009;0.001, respectively), but no significant differences when comparing other adjacent stages [<xref ref-type="bibr" rid="CR4">4</xref>]. They concluded that choriocapillaris flow density worsening does not entirely follow DR severity [<xref ref-type="bibr" rid="CR4">4</xref>].</p><p id="Par39">Dai et al. also reported no significant differences in the percentage or mean size of choriocapillaris flow deficit between patients with NPDR and PDR (<italic>P</italic>&#x02009;=&#x02009;1.000 for both) [<xref ref-type="bibr" rid="CR1">1</xref>]. They proposed that as diabetes progresses, various complicated microangiopathic changes occur in diabetic choriocapillaris [<xref ref-type="bibr" rid="CR1">1</xref>]. For example, narrowed choriocapillaris lumina and choriocapillaris dropouts contribute to increase in flow deficit size and percentage while formation of microaneurysms, capillary dilation and vascular loops can lead to decreased flow deficit size and percentage [<xref ref-type="bibr" rid="CR1">1</xref>]. Moreover, they noted that the current OCTA system&#x02019;s limited lateral resolution prevents detailed analysis of individual choriocapillaris for subtle morphological changes [<xref ref-type="bibr" rid="CR1">1</xref>]. This makes it unclear why there is no notable correlation between diabetic choroidopathy and DR severity [<xref ref-type="bibr" rid="CR1">1</xref>].</p></sec><sec id="Sec7"><title>Correlation between choroid perfusion parameters and visual function</title><p id="Par40">OCTA can detect small nonperfusion areas at the choriocapillaris level as areas of flow void [<xref ref-type="bibr" rid="CR47">47</xref>]. Since the RPE, outer retinal layers, and photoreceptors are mainly nourished by the choroidal vasculature, a flow void at the choriocapillaris level may result in damage and disruption to the outer retinal layers [<xref ref-type="bibr" rid="CR47">47</xref>]. Consequently, previous studies have investigated the potential link between choroidal vascular plexus perfusion and visual acuity [<xref ref-type="bibr" rid="CR36">36</xref>, <xref ref-type="bibr" rid="CR43">43</xref>, <xref ref-type="bibr" rid="CR48">48</xref>]. For instance, Li et al. reported a negative correlation between logMAR best-corrected visual acuity (BCVA) and flow area in the choroidal capillary plexus [<xref ref-type="bibr" rid="CR48">48</xref>]. This negative correlation was also observed between logMAR BCVA and choroidal vascular density in the foveal and parafoveal areas [<xref ref-type="bibr" rid="CR48">48</xref>]. Similarly, Ghassemi et al. found a positive correlation between BCVA (decimal) and choriocapillaris vascular density in the foveal area (<italic>r</italic>&#x02009;=&#x02009;0.233, <italic>P</italic>&#x02009;=&#x02009;0.0021) [<xref ref-type="bibr" rid="CR43">43</xref>]. Kaderli et al. also observed a significantly reduced choriocapillaris flow area in PDR patients with poorer vision (visual acuity&#x02009;&#x0003e;&#x02009;0.2 logMAR) compared to those with better vision and PDR [<xref ref-type="bibr" rid="CR49">49</xref>].</p><p id="Par41">Several studies have also investigated the potential association between retinal photoreceptor function and choroidal vasculature flow [<xref ref-type="bibr" rid="CR50">50</xref>, <xref ref-type="bibr" rid="CR51">51</xref>]. For example, Bandello et al. identified a significant inverse correlation between the percentage of choriocapillaris flow deficit and mesopic sensitivity in the foveal and parafoveal regions, as well as parafoveal dark-adapted sensitivity (&#x003b2; = -0.234, <italic>P</italic>&#x02009;=&#x02009;0.046; &#x003b2; = -0.312, <italic>P</italic>&#x02009;=&#x02009;0.032; and &#x003b2; = -0.282, <italic>P</italic>&#x02009;=&#x02009;0.048, respectively) [<xref ref-type="bibr" rid="CR50">50</xref>]. This suggests that macular hypoperfusion may contribute to dysfunction in both rod and cone activities [<xref ref-type="bibr" rid="CR50">50</xref>]. Ro-Mase et al. also found a significant association between foveal and choriocapillaris flow deficit and retinal sensitivity in individuals with NPDR and PDR [<xref ref-type="bibr" rid="CR51">51</xref>]. The correlation was significant for both the foveal (<italic>r</italic> = -0.58; <italic>P</italic>&#x02009;=&#x02009;0.046 and <italic>r</italic> = -0.82; <italic>P</italic>&#x02009;=&#x02009;0.003, respectively) and parafoveal regions (<italic>r</italic> = -0.59; <italic>P</italic>&#x02009;=&#x02009;0.044 and <italic>r</italic> = -0.72; <italic>P</italic>&#x02009;=&#x02009;0.019, respectively), but not in the control and NDR groups [<xref ref-type="bibr" rid="CR51">51</xref>]. However, they found no significant differences in cone heterogeneity packing index (HPi) across all groups [<xref ref-type="bibr" rid="CR51">51</xref>].</p><p id="Par42">Viggiano et al. reported a strong association between cone metrics and choriocapillaris flow deficit in individuals with NPDR [<xref ref-type="bibr" rid="CR52">52</xref>]. Specifically, an increase in choriocapillaris flow deficit percentage was linked to a rise in the linear dispersion index (LDi) (<italic>P</italic>&#x02009;=&#x02009;0.035), while a higher choriocapillaris flow deficit percentage was associated with a decrease in cone density (<italic>P</italic>&#x02009;=&#x02009;0.042) and HPi (<italic>P</italic>&#x02009;=&#x02009;0.017) [<xref ref-type="bibr" rid="CR52">52</xref>]. In a related study, Fragiotta et al. found that LDi and HPi were primarily affected by choriocapillaris perfusion and flow deficit percentage in the parafoveal area of eyes with mild NPDR (<italic>P</italic>&#x02009;=&#x02009;0.02) [<xref ref-type="bibr" rid="CR28">28</xref>]. They also reported a progressive deterioration of these cone metrics over time due to worsening choriocapillaris perfusion deficit [<xref ref-type="bibr" rid="CR28">28</xref>].</p><p id="Par43">Other studies have explored the relationship between alterations in the choriocapillaris and morpho-functional characteristics of the outer retina in individuals with diabetes [<xref ref-type="bibr" rid="CR53">53</xref>, <xref ref-type="bibr" rid="CR54">54</xref>]. For instance, Parravano et al. quantitatively assessed photoreceptor structural integrity by measuring the reflectivity of the ellipsoid zone (EZ) [<xref ref-type="bibr" rid="CR53">53</xref>]. They also used the multifocal electroretinogram (mfERG) response amplitude density (RAD) to evaluate the functional responses of the outer retina [<xref ref-type="bibr" rid="CR53">53</xref>]. Their results indicated that the average values of EZ &#x0201c;normalized&#x0201d; reflectivity, mfERG RAD, choriocapillaris flow deficit number, and percentage did not differ significantly between the NPDR and NDR groups (<italic>P</italic>&#x02009;&#x0003e;&#x02009;0.05) [<xref ref-type="bibr" rid="CR53">53</xref>]. However, a negative correlation was found between EZ &#x0201c;normalized&#x0201d; reflectivity and choriocapillaris flow deficit percentage in the NDR group [<xref ref-type="bibr" rid="CR53">53</xref>]. They also found a significant association between abnormal outer retinal function (reduced mfERG RAD) and choriocapillaris characteristics (increased flow deficit area and percentage) in the NPDR group [<xref ref-type="bibr" rid="CR53">53</xref>]. They hypothesized that the functional impairment of outer retinal elements in patients with NPDR may be proportionate to the deficit in choriocapillaris vascular supply [<xref ref-type="bibr" rid="CR53">53</xref>].</p><p id="Par44">Borrelli et al. reported impaired perfusion in both retinal and choroidal vasculature, along with lower EZ &#x0201c;normalized&#x0201d; reflectivity in patients with NPDR compared to controls (<italic>P</italic>&#x02009;&#x0003c;&#x02009;0.0001) [<xref ref-type="bibr" rid="CR54">54</xref>]. Multiple regression analysis revealed a significant direct association between EZ &#x0201c;normalized&#x0201d; reflectivity and choriocapillaris perfusion density in NPDR patients (<italic>P</italic>&#x02009;=&#x02009;0.025), an association not observed in controls (<italic>P</italic>&#x02009;=&#x02009;0.476) [<xref ref-type="bibr" rid="CR54">54</xref>]. Additionally, Deng et al. found a significant correlation between choriocapillaris flow and electroretinogram (ERG) parameters [<xref ref-type="bibr" rid="CR31">31</xref>]. They noted a significant progressive increase in the implicit time of the 30&#x000a0;Hz flicker ERG, from the healthy control group to the NDR group, and further to the DR group (<italic>P</italic>&#x02009;&#x0003c;&#x02009;0.05) [<xref ref-type="bibr" rid="CR31">31</xref>].</p></sec><sec id="Sec8"><title>Correlation between choroid perfusion parameters and systemic conditions</title><p id="Par45">Several studies have explored the potential association between systemic medical conditions and choriocapillaris perfusion in diabetic patients [<xref ref-type="bibr" rid="CR4">4</xref>, <xref ref-type="bibr" rid="CR25">25</xref>, <xref ref-type="bibr" rid="CR27">27</xref>, <xref ref-type="bibr" rid="CR55">55</xref>]. For example, Dimitrova et al. reported a significant negative correlation between the density and flow index of the choriocapillaris and diastolic blood pressure in the parafoveal area of patients with type 2 diabetes mellitus and no DR (<italic>r</italic> = -0.42, <italic>P</italic>&#x02009;=&#x02009;0.02) [<xref ref-type="bibr" rid="CR25">25</xref>].</p><p id="Par46">Yang et al. used multiple linear regression analyses to investigate the correlation between systemic medical conditions and choriocapillaris flow density [<xref ref-type="bibr" rid="CR4">4</xref>]. Their results showed a significant correlation between choriocapillaris flow density in the choriocapillaris layer and factors such as HbA1C, coronary artery disease, atherosclerosis in other locations, estimated glomerular filtration rate, and axial length of the eyes [<xref ref-type="bibr" rid="CR4">4</xref>]. They also found a significant association between dyslipidemia and choriocapillaris flow density in the choriocapillaris layer on 6-mm scan patterns [<xref ref-type="bibr" rid="CR4">4</xref>].</p><p id="Par47">Additionally, Agra et al. found a positive correlation between fasting blood glucose levels and choriocapillaris flow area (<italic>P</italic>&#x02009;=&#x02009;0.034) [<xref ref-type="bibr" rid="CR27">27</xref>]. In another study, Ucgul Atilgan et al. reported significant negative associations among diabetes duration, creatinine, urea, serum sodium, and specific choriocapillaris vessel density values, with all correlations showing p-values below 0.05 [<xref ref-type="bibr" rid="CR55">55</xref>].</p></sec><sec id="Sec9"><title>Powers and limitations</title><p id="Par48">This review provides an extensive evaluation of relevant studies assessing OCTA parameters for diabetic choroidopathy. The systematic approach adopted in this study helps gauge the usefulness of various OCTA indices as diagnostic and prognostic tools in patients with diabetes. We believe that a meta-analysis would be of limited value and potentially misleading due to significant heterogeneity among the studies in terms of methodology, population, devices used, outcome measures, and severity of diabetic retinopathy. The findings of this review should be considered in the context of the target population and should not be generalized to individuals with different demographic or clinical characteristics, or to devices with different specifications.</p></sec></sec><sec id="Sec10" sec-type="discussion"><title>Discussion</title><p id="Par49">The findings from several studies indicate a notable reduction in choroidal perfusion parameters during the preclinical stages of diabetes compared to the healthy population [<xref ref-type="bibr" rid="CR6">6</xref>, <xref ref-type="bibr" rid="CR14">14</xref>&#x02013;<xref ref-type="bibr" rid="CR19">19</xref>, <xref ref-type="bibr" rid="CR56">56</xref>]. However, some studies have claimed that diabetic patients without DR do not exhibit significant variations in choroidal vascular indices [<xref ref-type="bibr" rid="CR23">23</xref>, <xref ref-type="bibr" rid="CR24">24</xref>, <xref ref-type="bibr" rid="CR26">26</xref>, <xref ref-type="bibr" rid="CR27">27</xref>]. Therefore, while OCTA can aid in the early diagnosis of choroidal microangiopathy, it is essential to emphasize that OCTA should not be used as a substitute for clinical examinations.</p><p id="Par50">In addition, although many studies have demonstrated a stage-sensitive decline in choroidal microvasculature with increasing disease severity, some researchers have questioned the correlation between choroidal vascular alterations and DR stage. This raises the possibility that diabetic choroidopathy may be a consequence of diabetes itself rather than a contributing factor to the pathogenesis of DR [<xref ref-type="bibr" rid="CR57">57</xref>].</p><p id="Par51">OCTA of the choriocapillaris can also be used to predict changes in visual function. Since the RPE, outer retinal layers, and photoreceptors primarily rely on oxygenation and nourishment from the choroidal vasculature, a reduction in choriocapillaris perfusion could contribute to a decline in visual function. Previous studies have proposed a link between choroidal vasculature flow in diabetic patients and the morpho-functional characteristics of the outer retina and photoreceptors.</p><p id="Par52">It is important to consider the influence of confounding factors and concurrent health conditions that may affect choroidal circulation when evaluating the choroid in diabetic patients. These factors include, but are not limited to, aging, hypertension, nephropathies, dyslipidemia, coronary artery disease, and atherosclerosis in various regions of the body.</p></sec><sec id="Sec11" sec-type="supplementary-material"><title>Electronic supplementary material</title><p>Below is the link to the electronic supplementary material.</p><p>
<supplementary-material content-type="local-data" id="MOESM1"><media xlink:href="40942_2024_618_MOESM1_ESM.docx"><caption><p>Supplementary Material 1</p></caption></media></supplementary-material>
</p></sec></body><back><glossary><title>Abbreviations</title><def-list><def-item><term>DR</term><def><p id="Par750">Diabetic Retinopathy</p></def></def-item><def-item><term>ICGA</term><def><p id="Par760">Indocyanine Green Angiography</p></def></def-item><def-item><term>OCTA</term><def><p id="Par770">Optical Coherence Tomography Angiography</p></def></def-item><def-item><term>PRISMA</term><def><p id="Par780">Preferred Reporting Items for Systematic Reviews and Meta-analyses</p></def></def-item><def-item><term>SS-OCTA</term><def><p id="Par790">Swept-Source Optical Coherence Tomography Angiography</p></def></def-item><def-item><term>SD-OCTA</term><def><p id="Par710">Spectral-Domain Optical Coherence Tomography Angiography</p></def></def-item><def-item><term>RPE</term><def><p id="Par711">Retinal Pigment Epithelium</p></def></def-item><def-item><term>NDR</term><def><p id="Par712">Diabetic Eyes without Diabetic Retinopathy</p></def></def-item><def-item><term>CVI</term><def><p id="Par713">Choroid Vascularity Index</p></def></def-item><def-item><term>DCP</term><def><p id="Par714">Deep Capillary Plexus</p></def></def-item><def-item><term>SCP</term><def><p id="Par715">Superficial Capillary Plexus</p></def></def-item><def-item><term>NPDR</term><def><p id="Par716">Non-proliferative Diabetic Retinopathy</p></def></def-item><def-item><term>PDR</term><def><p id="Par717">Proliferative Diabetic Retinopathy</p></def></def-item><def-item><term>ETDRS</term><def><p id="Par718">Early Treatment Diabetic Retinopathy Study</p></def></def-item><def-item><term>BCVA</term><def><p id="Par719">Best-corrected Visual Acuity</p></def></def-item><def-item><term>HPi</term><def><p id="Par720">Heterogeneity Packing Index</p></def></def-item><def-item><term>LDi</term><def><p id="Par721">Linear Dispersion Index</p></def></def-item><def-item><term>EZ</term><def><p id="Par722">Ellipsoid Zone</p></def></def-item><def-item><term>ERG</term><def><p id="Par723">Electroretinogram</p></def></def-item><def-item><term>mfERG</term><def><p id="Par724">Multifocal Electroretinogram</p></def></def-item><def-item><term>RAD</term><def><p id="Par725">Response Amplitude Density</p></def></def-item></def-list></glossary><fn-group><fn><p><bold>Publisher&#x02019;s note</bold></p><p>Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.</p></fn></fn-group><ack><title>Acknowledgements</title><p>None.</p></ack><notes notes-type="author-contribution"><title>Author contributions</title><p>Both authors contributed to the conception and design of the study, collected the data, and participated in data analysis, interpretation, and manuscript writing. Both have read and approved the final version of the manuscript.</p></notes><notes notes-type="funding-information"><title>Funding</title><p>None to declare.</p></notes><notes notes-type="data-availability"><title>Data availability</title><p>No datasets were generated or analysed during the current study.</p></notes><notes><title>Declarations</title><notes id="FPar1"><title>Ethics approval and consent to participate</title><p id="Par53">This study was approved by the Shiraz University of Medical Sciences ethics committee (Shiraz, Iran) and was conducted in accordance with the ethical principles of the Declaration of Helsinki. Obtaining informed consent was not applicable to this study.</p></notes><notes id="FPar2"><title>Consent for publication</title><p id="Par54">Obtaining consent for publication was not applicable to this study.</p></notes><notes id="FPar3" notes-type="COI-statement"><title>Competing interests</title><p id="Par55">The authors declare no competing interests.</p></notes></notes><ref-list id="Bib1"><title>References</title><ref id="CR1"><label>1.</label><citation-alternatives><element-citation id="ec-CR1" publication-type="journal"><person-group person-group-type="author"><name><surname>Dai</surname><given-names>Y</given-names></name><name><surname>Zhou</surname><given-names>H</given-names></name><name><surname>Zhang</surname><given-names>Q</given-names></name><etal/></person-group><article-title>Quantitative assessment of choriocapillaris flow deficits in diabetic retinopathy: a swept-source optical coherence tomography angiography study</article-title><source>PLoS ONE</source><year>2020</year><volume>15</volume><issue>12</issue><fpage>e0243830</fpage><pub-id pub-id-type="doi">10.1371/journal.pone.0243830</pub-id><pub-id pub-id-type="pmid">33306736</pub-id>
</element-citation><mixed-citation id="mc-CR1" publication-type="journal">Dai Y, Zhou H, Zhang Q, et al. Quantitative assessment of choriocapillaris flow deficits in diabetic retinopathy: a swept-source optical coherence tomography angiography study. PLoS ONE. 2020;15(12):e0243830.<pub-id pub-id-type="pmid">33306736</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR2"><label>2.</label><citation-alternatives><element-citation id="ec-CR2" publication-type="journal"><person-group person-group-type="author"><name><surname>Hidayat</surname><given-names>AA</given-names></name><name><surname>Fine</surname><given-names>BS</given-names></name></person-group><article-title>Diabetic choroidopathy. Light and electron microscopic observations of seven cases</article-title><source>Ophthalmology</source><year>1985</year><volume>92</volume><issue>4</issue><fpage>512</fpage><lpage>22</lpage><pub-id pub-id-type="doi">10.1016/S0161-6420(85)34013-7</pub-id><pub-id pub-id-type="pmid">2582331</pub-id>
</element-citation><mixed-citation id="mc-CR2" publication-type="journal">Hidayat AA, Fine BS. Diabetic choroidopathy. Light and electron microscopic observations of seven cases. Ophthalmology. 1985;92(4):512&#x02013;22.<pub-id pub-id-type="pmid">2582331</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR3"><label>3.</label><citation-alternatives><element-citation id="ec-CR3" publication-type="journal"><person-group person-group-type="author"><name><surname>Cao</surname><given-names>J</given-names></name><name><surname>McLeod</surname><given-names>S</given-names></name><name><surname>Merges</surname><given-names>CA</given-names></name><name><surname>Lutty</surname><given-names>GA</given-names></name></person-group><article-title>Choriocapillaris degeneration and related pathologic changes in human diabetic eyes</article-title><source>Arch Ophthalmol</source><year>1998</year><volume>116</volume><issue>5</issue><fpage>589</fpage><lpage>97</lpage><pub-id pub-id-type="doi">10.1001/archopht.116.5.589</pub-id><pub-id pub-id-type="pmid">9596494</pub-id>
</element-citation><mixed-citation id="mc-CR3" publication-type="journal">Cao J, McLeod S, Merges CA, Lutty GA. Choriocapillaris degeneration and related pathologic changes in human diabetic eyes. Arch Ophthalmol. 1998;116(5):589&#x02013;97.<pub-id pub-id-type="pmid">9596494</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR4"><label>4.</label><citation-alternatives><element-citation id="ec-CR4" publication-type="journal"><person-group person-group-type="author"><name><surname>Yang</surname><given-names>J</given-names></name><name><surname>Wang</surname><given-names>E</given-names></name><name><surname>Zhao</surname><given-names>X</given-names></name><etal/></person-group><article-title>Optical coherence tomography angiography analysis of the choriocapillary layer in treatment-na&#x000ef;ve diabetic eyes</article-title><source>Graefes Arch Clin Exp Ophthalmol</source><year>2019</year><volume>257</volume><issue>7</issue><fpage>1393</fpage><lpage>9</lpage><pub-id pub-id-type="doi">10.1007/s00417-019-04326-x</pub-id><pub-id pub-id-type="pmid">31089870</pub-id>
</element-citation><mixed-citation id="mc-CR4" publication-type="journal">Yang J, Wang E, Zhao X, et al. Optical coherence tomography angiography analysis of the choriocapillary layer in treatment-na&#x000ef;ve diabetic eyes. Graefes Arch Clin Exp Ophthalmol. 2019;257(7):1393&#x02013;9.<pub-id pub-id-type="pmid">31089870</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR5"><label>5.</label><citation-alternatives><element-citation id="ec-CR5" publication-type="journal"><person-group person-group-type="author"><name><surname>Choi</surname><given-names>W</given-names></name><name><surname>Waheed</surname><given-names>NK</given-names></name><name><surname>Moult</surname><given-names>EM</given-names></name><etal/></person-group><article-title>Ultrahigh speed swept source optical coherence tomography angiography of retinal and choriocapillaris alterations in diabetic patients with and without retinopathy</article-title><source>Retina</source><year>2017</year><volume>37</volume><issue>1</issue><fpage>11</fpage><lpage>21</lpage><pub-id pub-id-type="doi">10.1097/IAE.0000000000001250</pub-id><pub-id pub-id-type="pmid">27557084</pub-id>
</element-citation><mixed-citation id="mc-CR5" publication-type="journal">Choi W, Waheed NK, Moult EM, et al. Ultrahigh speed swept source optical coherence tomography angiography of retinal and choriocapillaris alterations in diabetic patients with and without retinopathy. Retina. 2017;37(1):11&#x02013;21.<pub-id pub-id-type="pmid">27557084</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR6"><label>6.</label><citation-alternatives><element-citation id="ec-CR6" publication-type="journal"><person-group person-group-type="author"><name><surname>Dai</surname><given-names>Y</given-names></name><name><surname>Zhou</surname><given-names>H</given-names></name><name><surname>Chu</surname><given-names>Z</given-names></name><etal/></person-group><article-title>Microvascular changes in the choriocapillaris of diabetic patients without retinopathy investigated by swept-source OCT angiography</article-title><source>Invest Ophthalmol Vis Sci</source><year>2020</year><volume>61</volume><issue>3</issue><fpage>50</fpage><pub-id pub-id-type="doi">10.1167/iovs.61.3.50</pub-id><pub-id pub-id-type="pmid">32232345</pub-id>
</element-citation><mixed-citation id="mc-CR6" publication-type="journal">Dai Y, Zhou H, Chu Z, et al. Microvascular changes in the choriocapillaris of diabetic patients without retinopathy investigated by swept-source OCT angiography. Invest Ophthalmol Vis Sci. 2020;61(3):50.<pub-id pub-id-type="pmid">32232345</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR7"><label>7.</label><citation-alternatives><element-citation id="ec-CR7" publication-type="journal"><person-group person-group-type="author"><name><surname>Gendelman</surname><given-names>I</given-names></name><name><surname>Alibhai</surname><given-names>AY</given-names></name><name><surname>Moult</surname><given-names>EM</given-names></name><etal/></person-group><article-title>Topographic analysis of macular choriocapillaris flow deficits in diabetic retinopathy using swept&#x02013;source optical coherence tomography angiography</article-title><source>Int J Retina Vitreous</source><year>2020</year><volume>6</volume><issue>1</issue><fpage>6</fpage><pub-id pub-id-type="doi">10.1186/s40942-020-00209-0</pub-id><pub-id pub-id-type="pmid">32206342</pub-id>
</element-citation><mixed-citation id="mc-CR7" publication-type="journal">Gendelman I, Alibhai AY, Moult EM, et al. Topographic analysis of macular choriocapillaris flow deficits in diabetic retinopathy using swept&#x02013;source optical coherence tomography angiography. Int J Retina Vitreous. 2020;6(1):6.<pub-id pub-id-type="pmid">32206342</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR8"><label>8.</label><citation-alternatives><element-citation id="ec-CR8" publication-type="journal"><person-group person-group-type="author"><name><surname>Namvar</surname><given-names>E</given-names></name><name><surname>Ahmadieh</surname><given-names>H</given-names></name><name><surname>Maleki</surname><given-names>A</given-names></name><name><surname>Nowroozzadeh</surname><given-names>MH</given-names></name></person-group><article-title>Sensitivity and specificity of optical coherence tomography angiography for diagnosis and classification of diabetic retinopathy; a systematic review and meta-analysis</article-title><source>Eur J Ophthalmol</source><year>2023</year><volume>33</volume><issue>6</issue><fpage>2068</fpage><lpage>78</lpage><pub-id pub-id-type="doi">10.1177/11206721231167458</pub-id><pub-id pub-id-type="pmid">37013361</pub-id>
</element-citation><mixed-citation id="mc-CR8" publication-type="journal">Namvar E, Ahmadieh H, Maleki A, Nowroozzadeh MH. Sensitivity and specificity of optical coherence tomography angiography for diagnosis and classification of diabetic retinopathy; a systematic review and meta-analysis. Eur J Ophthalmol. 2023;33(6):2068&#x02013;78.<pub-id pub-id-type="pmid">37013361</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR9"><label>9.</label><citation-alternatives><element-citation id="ec-CR9" publication-type="journal"><person-group person-group-type="author"><name><surname>Saif</surname><given-names>PS</given-names></name><name><surname>Salman</surname><given-names>AEG</given-names></name><name><surname>Omran</surname><given-names>NAH</given-names></name><name><surname>Farweez</surname><given-names>YAT</given-names></name></person-group><article-title>Assessment of diabetic retinopathy vascular density maps</article-title><source>Clin Ophthalmol</source><year>2020</year><volume>14</volume><fpage>3941</fpage><lpage>53</lpage><pub-id pub-id-type="doi">10.2147/OPTH.S256963</pub-id><pub-id pub-id-type="pmid">33239860</pub-id>
</element-citation><mixed-citation id="mc-CR9" publication-type="journal">Saif PS, Salman AEG, Omran NAH, Farweez YAT. Assessment of diabetic retinopathy vascular density maps. Clin Ophthalmol. 2020;14:3941&#x02013;53.<pub-id pub-id-type="pmid">33239860</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR10"><label>10.</label><citation-alternatives><element-citation id="ec-CR10" publication-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname><given-names>Y</given-names></name><name><surname>Qin</surname><given-names>Y</given-names></name><name><surname>Wang</surname><given-names>S</given-names></name><name><surname>Liu</surname><given-names>Y</given-names></name><name><surname>Li</surname><given-names>X</given-names></name><name><surname>Sun</surname><given-names>X</given-names></name></person-group><article-title>Higher choroidal thickness and lower choriocapillaris blood flow signal density based on optical coherence tomography angiography in diabetics</article-title><source>Sci Rep</source><year>2021</year><volume>11</volume><issue>1</issue><fpage>5799</fpage><pub-id pub-id-type="doi">10.1038/s41598-021-85065-0</pub-id><pub-id pub-id-type="pmid">33707607</pub-id>
</element-citation><mixed-citation id="mc-CR10" publication-type="journal">Zhang Y, Qin Y, Wang S, Liu Y, Li X, Sun X. Higher choroidal thickness and lower choriocapillaris blood flow signal density based on optical coherence tomography angiography in diabetics. Sci Rep. 2021;11(1):5799.<pub-id pub-id-type="pmid">33707607</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR11"><label>11.</label><citation-alternatives><element-citation id="ec-CR11" publication-type="journal"><person-group person-group-type="author"><name><surname>Page</surname><given-names>MJ</given-names></name><name><surname>McKenzie</surname><given-names>JE</given-names></name><name><surname>Bossuyt</surname><given-names>PM</given-names></name><etal/></person-group><article-title>The PRISMA 2020 statement: an updated guideline for reporting systematic reviews</article-title><source>BMJ</source><year>2021</year><volume>372</volume><fpage>n71</fpage><pub-id pub-id-type="doi">10.1136/bmj.n71</pub-id><pub-id pub-id-type="pmid">33782057</pub-id>
</element-citation><mixed-citation id="mc-CR11" publication-type="journal">Page MJ, McKenzie JE, Bossuyt PM, et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ. 2021;372:n71.<pub-id pub-id-type="pmid">33782057</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR12"><label>12.</label><citation-alternatives><element-citation id="ec-CR12" publication-type="journal"><person-group person-group-type="author"><name><surname>Stang</surname><given-names>A</given-names></name></person-group><article-title>Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analyses</article-title><source>Eur J Epidemiol</source><year>2010</year><volume>25</volume><issue>9</issue><fpage>603</fpage><lpage>5</lpage><pub-id pub-id-type="doi">10.1007/s10654-010-9491-z</pub-id><pub-id pub-id-type="pmid">20652370</pub-id>
</element-citation><mixed-citation id="mc-CR12" publication-type="journal">Stang A. Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analyses. Eur J Epidemiol. 2010;25(9):603&#x02013;5.<pub-id pub-id-type="pmid">20652370</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR13"><label>13.</label><citation-alternatives><element-citation id="ec-CR13" publication-type="journal"><person-group person-group-type="author"><name><surname>Vujosevic</surname><given-names>S</given-names></name><name><surname>Cunha-Vaz</surname><given-names>J</given-names></name><name><surname>Figueira</surname><given-names>J</given-names></name><etal/></person-group><article-title>Standardization of optical coherence tomography angiography imaging biomarkers in diabetic retinal disease</article-title><source>Ophthalmic Res</source><year>2021</year><volume>64</volume><issue>6</issue><fpage>871</fpage><lpage>87</lpage><pub-id pub-id-type="doi">10.1159/000518620</pub-id><pub-id pub-id-type="pmid">34348330</pub-id>
</element-citation><mixed-citation id="mc-CR13" publication-type="journal">Vujosevic S, Cunha-Vaz J, Figueira J, et al. Standardization of optical coherence tomography angiography imaging biomarkers in diabetic retinal disease. Ophthalmic Res. 2021;64(6):871&#x02013;87.<pub-id pub-id-type="pmid">34348330</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR14"><label>14.</label><citation-alternatives><element-citation id="ec-CR14" publication-type="journal"><person-group person-group-type="author"><name><surname>Forte</surname><given-names>R</given-names></name><name><surname>Haulani</surname><given-names>H</given-names></name><name><surname>J&#x000fc;rgens</surname><given-names>I</given-names></name></person-group><article-title>Quantitative and qualitative analysis of the three capillary plexuses and choriocapillaris in patients with type 1 and type 2 diabetes mellitus without chinical signs of diabetic retinopathy: a prospective pilot study</article-title><source>Retina</source><year>2020</year><volume>40</volume><issue>2</issue><fpage>333</fpage><lpage>44</lpage><pub-id pub-id-type="doi">10.1097/IAE.0000000000002376</pub-id><pub-id pub-id-type="pmid">31972804</pub-id>
</element-citation><mixed-citation id="mc-CR14" publication-type="journal">Forte R, Haulani H, J&#x000fc;rgens I. Quantitative and qualitative analysis of the three capillary plexuses and choriocapillaris in patients with type 1 and type 2 diabetes mellitus without chinical signs of diabetic retinopathy: a prospective pilot study. Retina. 2020;40(2):333&#x02013;44.<pub-id pub-id-type="pmid">31972804</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR15"><label>15.</label><citation-alternatives><element-citation id="ec-CR15" publication-type="journal"><person-group person-group-type="author"><name><surname>Loria</surname><given-names>O</given-names></name><name><surname>Kodjikian</surname><given-names>L</given-names></name><name><surname>Denis</surname><given-names>P</given-names></name><etal/></person-group><article-title>Quantitative analysis of choriocapillaris alteration in swept-source optical coherence tomography angiography in diabetic patients</article-title><source>Retina</source><year>2021</year><volume>41</volume><issue>9</issue><fpage>1809</fpage><lpage>18</lpage><pub-id pub-id-type="doi">10.1097/IAE.0000000000003102</pub-id><pub-id pub-id-type="pmid">33411469</pub-id>
</element-citation><mixed-citation id="mc-CR15" publication-type="journal">Loria O, Kodjikian L, Denis P, et al. Quantitative analysis of choriocapillaris alteration in swept-source optical coherence tomography angiography in diabetic patients. Retina. 2021;41(9):1809&#x02013;18.<pub-id pub-id-type="pmid">33411469</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR16"><label>16.</label><mixed-citation publication-type="other">Zlatanovi&#x00107; M, &#x00110;or&#x00111;evi&#x00107; Joci&#x00107; J, Jak&#x00161;i&#x00107; V et al. The determination of type 2 diabetes mellitus&#x02019;s impact on the density of retinal blood vessels and the choriocapillaris: optical coherence tomography angiography study. J Ophthalmol. 2021; 2021: 7043251.</mixed-citation></ref><ref id="CR17"><label>17.</label><citation-alternatives><element-citation id="ec-CR17" publication-type="journal"><person-group person-group-type="author"><name><surname>Xiong</surname><given-names>K</given-names></name><name><surname>Wang</surname><given-names>W</given-names></name><name><surname>Gong</surname><given-names>X</given-names></name><etal/></person-group><article-title>Influence of high myopia on choriocapillaris perfusion and choroidal thickness in diabetci patients without diabetic retinopathy</article-title><source>Retina</source><year>2022</year><volume>42</volume><issue>6</issue><fpage>1077</fpage><lpage>84</lpage><pub-id pub-id-type="doi">10.1097/IAE.0000000000003427</pub-id><pub-id pub-id-type="pmid">35174807</pub-id>
</element-citation><mixed-citation id="mc-CR17" publication-type="journal">Xiong K, Wang W, Gong X, et al. Influence of high myopia on choriocapillaris perfusion and choroidal thickness in diabetci patients without diabetic retinopathy. Retina. 2022;42(6):1077&#x02013;84.<pub-id pub-id-type="pmid">35174807</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR18"><label>18.</label><citation-alternatives><element-citation id="ec-CR18" publication-type="journal"><person-group person-group-type="author"><name><surname>Li</surname><given-names>Z</given-names></name><name><surname>Alzogool</surname><given-names>M</given-names></name><name><surname>Xiao</surname><given-names>J</given-names></name><name><surname>Zhang</surname><given-names>S</given-names></name><name><surname>Zeng</surname><given-names>P</given-names></name><name><surname>Lan</surname><given-names>Y</given-names></name></person-group><article-title>Optical coherence tomography angiography findings of neurovascular changes in type 2 diabetes mellitus patients without clinical diabetic retinopathy</article-title><source>Acta Diabetol</source><year>2018</year><volume>55</volume><issue>10</issue><fpage>1075</fpage><lpage>82</lpage><pub-id pub-id-type="doi">10.1007/s00592-018-1202-3</pub-id><pub-id pub-id-type="pmid">30066044</pub-id>
</element-citation><mixed-citation id="mc-CR18" publication-type="journal">Li Z, Alzogool M, Xiao J, Zhang S, Zeng P, Lan Y. Optical coherence tomography angiography findings of neurovascular changes in type 2 diabetes mellitus patients without clinical diabetic retinopathy. Acta Diabetol. 2018;55(10):1075&#x02013;82.<pub-id pub-id-type="pmid">30066044</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR19"><label>19.</label><citation-alternatives><element-citation id="ec-CR19" publication-type="journal"><person-group person-group-type="author"><name><surname>Stulova</surname><given-names>AN</given-names></name><name><surname>Semenova</surname><given-names>NS</given-names></name><name><surname>Zheleznyakova</surname><given-names>AV</given-names></name><name><surname>Akopyan</surname><given-names>VS</given-names></name><name><surname>Lipatov</surname><given-names>DV</given-names></name></person-group><article-title>OCTA and functional signs of preclinical retinopathy in type 1 diabetes mellitus</article-title><source>Ophthalmic Surg Lasers Imaging Retina</source><year>2021</year><volume>52</volume><issue>S1</issue><fpage>S30</fpage><lpage>4</lpage><pub-id pub-id-type="doi">10.3928/23258160-20210518-06</pub-id><pub-id pub-id-type="pmid">34310241</pub-id>
</element-citation><mixed-citation id="mc-CR19" publication-type="journal">Stulova AN, Semenova NS, Zheleznyakova AV, Akopyan VS, Lipatov DV. OCTA and functional signs of preclinical retinopathy in type 1 diabetes mellitus. Ophthalmic Surg Lasers Imaging Retina. 2021;52(S1):S30&#x02013;4.<pub-id pub-id-type="pmid">34310241</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR20"><label>20.</label><citation-alternatives><element-citation id="ec-CR20" publication-type="journal"><person-group person-group-type="author"><name><surname>Tan</surname><given-names>B</given-names></name><name><surname>Lim</surname><given-names>NA</given-names></name><name><surname>Tan</surname><given-names>R</given-names></name><etal/></person-group><article-title>Combining retinal and choroidal microvascular metrics improves discriminative power for diabetic retinopathy</article-title><source>Br J Ophthalmol</source><year>2023</year><volume>107</volume><issue>7</issue><fpage>993</fpage><lpage>9</lpage><pub-id pub-id-type="doi">10.1136/bjophthalmol-2021-319739</pub-id><pub-id pub-id-type="pmid">35140059</pub-id>
</element-citation><mixed-citation id="mc-CR20" publication-type="journal">Tan B, Lim NA, Tan R, et al. Combining retinal and choroidal microvascular metrics improves discriminative power for diabetic retinopathy. Br J Ophthalmol. 2023;107(7):993&#x02013;9.<pub-id pub-id-type="pmid">35140059</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR21"><label>21.</label><mixed-citation publication-type="other">Xu F, Li Z, Yang X et al. Assessment of choroidal structural changes in patients with pre- and early-stage clinical diabetic retinopathy using wide-field SS-OCTA. Front Endocrinol 2023. 13.</mixed-citation></ref><ref id="CR22"><label>22.</label><citation-alternatives><element-citation id="ec-CR22" publication-type="journal"><person-group person-group-type="author"><name><surname>Aksoy</surname><given-names>M</given-names></name><name><surname>Simsek</surname><given-names>M</given-names></name><name><surname>Apayd&#x00131;n</surname><given-names>M</given-names></name></person-group><article-title>Choroidal vascularity index in patients with type-1 diabetes mellitus without diabetic retinopathy</article-title><source>Curr Eye Res</source><year>2021</year><volume>46</volume><issue>6</issue><fpage>865</fpage><lpage>70</lpage><pub-id pub-id-type="doi">10.1080/02713683.2020.1846755</pub-id><pub-id pub-id-type="pmid">33141614</pub-id>
</element-citation><mixed-citation id="mc-CR22" publication-type="journal">Aksoy M, Simsek M, Apayd&#x00131;n M. Choroidal vascularity index in patients with type-1 diabetes mellitus without diabetic retinopathy. Curr Eye Res. 2021;46(6):865&#x02013;70.<pub-id pub-id-type="pmid">33141614</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR23"><label>23.</label><citation-alternatives><element-citation id="ec-CR23" publication-type="journal"><person-group person-group-type="author"><name><surname>Sacconi</surname><given-names>R</given-names></name><name><surname>Casaluci</surname><given-names>M</given-names></name><name><surname>Borrelli</surname><given-names>E</given-names></name><etal/></person-group><article-title>Multimodal imaging assessment of vascular and neurodegenerative retinal alterations in type 1 diabetic patients without fundoscopic signs of diabetic retinopathy</article-title><source>J Clin Med</source><year>2019</year><volume>8</volume><issue>9</issue><fpage>1409</fpage><pub-id pub-id-type="doi">10.3390/jcm8091409</pub-id><pub-id pub-id-type="pmid">31500344</pub-id>
</element-citation><mixed-citation id="mc-CR23" publication-type="journal">Sacconi R, Casaluci M, Borrelli E, et al. Multimodal imaging assessment of vascular and neurodegenerative retinal alterations in type 1 diabetic patients without fundoscopic signs of diabetic retinopathy. J Clin Med. 2019;8(9):1409.<pub-id pub-id-type="pmid">31500344</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR24"><label>24.</label><citation-alternatives><element-citation id="ec-CR24" publication-type="journal"><person-group person-group-type="author"><name><surname>Carnevali</surname><given-names>A</given-names></name><name><surname>Sacconi</surname><given-names>R</given-names></name><name><surname>Corbelli</surname><given-names>E</given-names></name><etal/></person-group><article-title>Optical coherence tomography angiography analysis of retinal vascular plexuses and choriocapillaris in patients with type 1 diabetes without diabetic retinopathy</article-title><source>Acta Diabetol</source><year>2017</year><volume>54</volume><issue>7</issue><fpage>695</fpage><lpage>702</lpage><pub-id pub-id-type="doi">10.1007/s00592-017-0996-8</pub-id><pub-id pub-id-type="pmid">28474119</pub-id>
</element-citation><mixed-citation id="mc-CR24" publication-type="journal">Carnevali A, Sacconi R, Corbelli E, et al. Optical coherence tomography angiography analysis of retinal vascular plexuses and choriocapillaris in patients with type 1 diabetes without diabetic retinopathy. Acta Diabetol. 2017;54(7):695&#x02013;702.<pub-id pub-id-type="pmid">28474119</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR25"><label>25.</label><citation-alternatives><element-citation id="ec-CR25" publication-type="journal"><person-group person-group-type="author"><name><surname>Dimitrova</surname><given-names>G</given-names></name><name><surname>Chihara</surname><given-names>E</given-names></name><name><surname>Takahashi</surname><given-names>H</given-names></name><name><surname>Amano</surname><given-names>H</given-names></name><name><surname>Okazaki</surname><given-names>K</given-names></name></person-group><article-title>Quantitative retinal optical coherence tomography angiography in patients with diabetes without diabetic retinopathy</article-title><source>Invest Ophthalmol Vis Sci</source><year>2017</year><volume>58</volume><issue>1</issue><fpage>190</fpage><lpage>6</lpage><pub-id pub-id-type="doi">10.1167/iovs.16-20531</pub-id><pub-id pub-id-type="pmid">28114579</pub-id>
</element-citation><mixed-citation id="mc-CR25" publication-type="journal">Dimitrova G, Chihara E, Takahashi H, Amano H, Okazaki K. Quantitative retinal optical coherence tomography angiography in patients with diabetes without diabetic retinopathy. Invest Ophthalmol Vis Sci. 2017;58(1):190&#x02013;6.<pub-id pub-id-type="pmid">28114579</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR26"><label>26.</label><citation-alternatives><element-citation id="ec-CR26" publication-type="journal"><person-group person-group-type="author"><name><surname>Conti</surname><given-names>FF</given-names></name><name><surname>Qin</surname><given-names>VL</given-names></name><name><surname>Rodrigues</surname><given-names>EB</given-names></name><etal/></person-group><article-title>Choriocapillaris and retinal vascular plexus density of diabetic eyes using split-spectrum amplitude decorrelation spectral-domain optical coherence tomography angiography</article-title><source>Br J Ophthalmol</source><year>2019</year><volume>103</volume><issue>4</issue><fpage>452</fpage><lpage>6</lpage><pub-id pub-id-type="doi">10.1136/bjophthalmol-2018-311903</pub-id><pub-id pub-id-type="pmid">29793926</pub-id>
</element-citation><mixed-citation id="mc-CR26" publication-type="journal">Conti FF, Qin VL, Rodrigues EB, et al. Choriocapillaris and retinal vascular plexus density of diabetic eyes using split-spectrum amplitude decorrelation spectral-domain optical coherence tomography angiography. Br J Ophthalmol. 2019;103(4):452&#x02013;6.<pub-id pub-id-type="pmid">29793926</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR27"><label>27.</label><citation-alternatives><element-citation id="ec-CR27" publication-type="journal"><person-group person-group-type="author"><name><surname>Agra</surname><given-names>C</given-names></name><name><surname>Lira</surname><given-names>RPC</given-names></name><name><surname>Pinheiro</surname><given-names>FG</given-names></name><name><surname>S&#x000e1;</surname><given-names>L</given-names></name><name><surname>Bravo Filho</surname><given-names>VTF</given-names></name></person-group><article-title>Optical coherence tomography angiography: microvascular alterations in diabetic eyes without diabetic retinopathy</article-title><source>Arq Bras Oftalmol</source><year>2021</year><volume>84</volume><issue>2</issue><fpage>149</fpage><lpage>57</lpage><pub-id pub-id-type="doi">10.5935/0004-2749.20210023</pub-id><pub-id pub-id-type="pmid">33567012</pub-id>
</element-citation><mixed-citation id="mc-CR27" publication-type="journal">Agra C, Lira RPC, Pinheiro FG, S&#x000e1; L, Bravo Filho VTF. Optical coherence tomography angiography: microvascular alterations in diabetic eyes without diabetic retinopathy. Arq Bras Oftalmol. 2021;84(2):149&#x02013;57.<pub-id pub-id-type="pmid">33567012</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR28"><label>28.</label><citation-alternatives><element-citation id="ec-CR28" publication-type="journal"><person-group person-group-type="author"><name><surname>Fragiotta</surname><given-names>S</given-names></name><name><surname>Costanzo</surname><given-names>E</given-names></name><name><surname>Picconi</surname><given-names>F</given-names></name><etal/></person-group><article-title>Progression biomarkers of microvascular and photoreceptor changes upon long-term evaluation in type 1 diabetes</article-title><source>Invest Ophthalmol Vis Sci</source><year>2023</year><volume>64</volume><issue>5</issue><fpage>23</fpage><pub-id pub-id-type="doi">10.1167/iovs.64.5.23</pub-id><pub-id pub-id-type="pmid">37227747</pub-id>
</element-citation><mixed-citation id="mc-CR28" publication-type="journal">Fragiotta S, Costanzo E, Picconi F, et al. Progression biomarkers of microvascular and photoreceptor changes upon long-term evaluation in type 1 diabetes. Invest Ophthalmol Vis Sci. 2023;64(5):23.<pub-id pub-id-type="pmid">37227747</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR29"><label>29.</label><citation-alternatives><element-citation id="ec-CR29" publication-type="journal"><person-group person-group-type="author"><name><surname>Thaker</surname><given-names>S</given-names></name><name><surname>Kumar</surname><given-names>V</given-names></name><name><surname>Singh</surname><given-names>U</given-names></name><name><surname>Kumar</surname><given-names>S</given-names></name></person-group><article-title>Novel optical coherence tomography angiography biomarkers in the diagnosis and assessment of diabetic macular edema and diabetic macular ischemia in patients with non-proliferative diabetic retinopathy</article-title><source>Indian J Ophthalmol</source><year>2023</year><volume>71</volume><issue>1</issue><fpage>183</fpage><lpage>7</lpage><pub-id pub-id-type="doi">10.4103/ijo.IJO_1294_22</pub-id><pub-id pub-id-type="pmid">36588233</pub-id>
</element-citation><mixed-citation id="mc-CR29" publication-type="journal">Thaker S, Kumar V, Singh U, Kumar S. Novel optical coherence tomography angiography biomarkers in the diagnosis and assessment of diabetic macular edema and diabetic macular ischemia in patients with non-proliferative diabetic retinopathy. Indian J Ophthalmol. 2023;71(1):183&#x02013;7.<pub-id pub-id-type="pmid">36588233</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR30"><label>30.</label><citation-alternatives><element-citation id="ec-CR30" publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>W</given-names></name><name><surname>Guo</surname><given-names>X</given-names></name><name><surname>Chen</surname><given-names>Y</given-names></name><etal/></person-group><article-title>Choriocapillaris perfusion assessed using swept source optical coherence tomographic angiography and the severity of diabetic retinopathy</article-title><source>Br J Ophthalmol</source><year>2023</year><volume>107</volume><issue>6</issue><fpage>836</fpage><lpage>41</lpage><pub-id pub-id-type="doi">10.1136/bjophthalmol-2021-320163</pub-id><pub-id pub-id-type="pmid">35115302</pub-id>
</element-citation><mixed-citation id="mc-CR30" publication-type="journal">Wang W, Guo X, Chen Y, et al. Choriocapillaris perfusion assessed using swept source optical coherence tomographic angiography and the severity of diabetic retinopathy. Br J Ophthalmol. 2023;107(6):836&#x02013;41.<pub-id pub-id-type="pmid">35115302</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR31"><label>31.</label><citation-alternatives><element-citation id="ec-CR31" publication-type="journal"><person-group person-group-type="author"><name><surname>Deng</surname><given-names>X</given-names></name><name><surname>Li</surname><given-names>Z</given-names></name><name><surname>Zeng</surname><given-names>P</given-names></name><name><surname>Liang</surname><given-names>J</given-names></name><name><surname>Wang</surname><given-names>J</given-names></name><name><surname>Lan</surname><given-names>Y</given-names></name></person-group><article-title>The association between decreased choriocapillary flow and electroretinogram impairments in patients with diabetes</article-title><source>Photodiagnosis Photodyn Ther</source><year>2023</year><volume>42</volume><fpage>103547</fpage><pub-id pub-id-type="doi">10.1016/j.pdpdt.2023.103547</pub-id><pub-id pub-id-type="pmid">37003594</pub-id>
</element-citation><mixed-citation id="mc-CR31" publication-type="journal">Deng X, Li Z, Zeng P, Liang J, Wang J, Lan Y. The association between decreased choriocapillary flow and electroretinogram impairments in patients with diabetes. Photodiagnosis Photodyn Ther. 2023;42:103547.<pub-id pub-id-type="pmid">37003594</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR32"><label>32.</label><citation-alternatives><element-citation id="ec-CR32" publication-type="journal"><person-group person-group-type="author"><name><surname>Dodo</surname><given-names>Y</given-names></name><name><surname>Suzuma</surname><given-names>K</given-names></name><name><surname>Ishihara</surname><given-names>K</given-names></name><etal/></person-group><article-title>Clinical relevance of reduced decorrelation signals in the diabetic inner choroid on optical coherence tomography angiography</article-title><source>Sci Rep</source><year>2017</year><volume>7</volume><issue>1</issue><fpage>5227</fpage><pub-id pub-id-type="doi">10.1038/s41598-017-05663-9</pub-id><pub-id pub-id-type="pmid">28701715</pub-id>
</element-citation><mixed-citation id="mc-CR32" publication-type="journal">Dodo Y, Suzuma K, Ishihara K, et al. Clinical relevance of reduced decorrelation signals in the diabetic inner choroid on optical coherence tomography angiography. Sci Rep. 2017;7(1):5227.<pub-id pub-id-type="pmid">28701715</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR33"><label>33.</label><citation-alternatives><element-citation id="ec-CR33" publication-type="journal"><person-group person-group-type="author"><name><surname>Nagaoka</surname><given-names>T</given-names></name><name><surname>Kitaya</surname><given-names>N</given-names></name><name><surname>Sugawara</surname><given-names>R</given-names></name><etal/></person-group><article-title>Alteration of choroidal circulation in the foveal region in patients with type 2 diabetes</article-title><source>Br J Ophthalmol</source><year>2004</year><volume>88</volume><issue>8</issue><fpage>1060</fpage><lpage>3</lpage><pub-id pub-id-type="doi">10.1136/bjo.2003.035345</pub-id><pub-id pub-id-type="pmid">15258025</pub-id>
</element-citation><mixed-citation id="mc-CR33" publication-type="journal">Nagaoka T, Kitaya N, Sugawara R, et al. Alteration of choroidal circulation in the foveal region in patients with type 2 diabetes. Br J Ophthalmol. 2004;88(8):1060&#x02013;3.<pub-id pub-id-type="pmid">15258025</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR34"><label>34.</label><citation-alternatives><element-citation id="ec-CR34" publication-type="journal"><person-group person-group-type="author"><name><surname>Sim&#x000f3;</surname><given-names>R</given-names></name><name><surname>Villarroel</surname><given-names>M</given-names></name><name><surname>Corraliza</surname><given-names>L</given-names></name><name><surname>Hern&#x000e1;ndez</surname><given-names>C</given-names></name><name><surname>Garcia-Ram&#x000ed;rez</surname><given-names>M</given-names></name></person-group><article-title>The retinal pigment epithelium: something more than a constituent of the blood-retinal barrier&#x02013;implications for the pathogenesis of diabetic retinopathy</article-title><source>J Biomed Biotechnol</source><year>2010</year><volume>2010</volume><fpage>190724</fpage><pub-id pub-id-type="doi">10.1155/2010/190724</pub-id><pub-id pub-id-type="pmid">20182540</pub-id>
</element-citation><mixed-citation id="mc-CR34" publication-type="journal">Sim&#x000f3; R, Villarroel M, Corraliza L, Hern&#x000e1;ndez C, Garcia-Ram&#x000ed;rez M. The retinal pigment epithelium: something more than a constituent of the blood-retinal barrier&#x02013;implications for the pathogenesis of diabetic retinopathy. J Biomed Biotechnol. 2010;2010:190724.<pub-id pub-id-type="pmid">20182540</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR35"><label>35.</label><citation-alternatives><element-citation id="ec-CR35" publication-type="journal"><person-group person-group-type="author"><name><surname>Ashraf</surname><given-names>M</given-names></name><name><surname>Sampani</surname><given-names>K</given-names></name><name><surname>Rageh</surname><given-names>A</given-names></name><name><surname>Silva</surname><given-names>PS</given-names></name><name><surname>Aiello</surname><given-names>LP</given-names></name><name><surname>Sun</surname><given-names>JK</given-names></name></person-group><article-title>Interaction between the distribution of diabetic retinopathy lesions and the association of optical coherence tomography angiography scans with diabetic retinopathy severity</article-title><source>JAMA Ophthalmol</source><year>2020</year><volume>138</volume><issue>12</issue><fpage>1291</fpage><lpage>7</lpage><pub-id pub-id-type="doi">10.1001/jamaophthalmol.2020.4516</pub-id><pub-id pub-id-type="pmid">33119083</pub-id>
</element-citation><mixed-citation id="mc-CR35" publication-type="journal">Ashraf M, Sampani K, Rageh A, Silva PS, Aiello LP, Sun JK. Interaction between the distribution of diabetic retinopathy lesions and the association of optical coherence tomography angiography scans with diabetic retinopathy severity. JAMA Ophthalmol. 2020;138(12):1291&#x02013;7.<pub-id pub-id-type="pmid">33119083</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR36"><label>36.</label><citation-alternatives><element-citation id="ec-CR36" publication-type="journal"><person-group person-group-type="author"><name><surname>Rodrigues</surname><given-names>TM</given-names></name><name><surname>Marques</surname><given-names>JP</given-names></name><name><surname>Soares</surname><given-names>M</given-names></name><etal/></person-group><article-title>Macular OCT-angiography parameters to predict the clinical stage of nonproliferative diabetic retinopathy: an exploratory analysis</article-title><source>Eye (Lond)</source><year>2019</year><volume>33</volume><issue>8</issue><fpage>1240</fpage><lpage>7</lpage><pub-id pub-id-type="doi">10.1038/s41433-019-0401-7</pub-id><pub-id pub-id-type="pmid">30903092</pub-id>
</element-citation><mixed-citation id="mc-CR36" publication-type="journal">Rodrigues TM, Marques JP, Soares M, et al. Macular OCT-angiography parameters to predict the clinical stage of nonproliferative diabetic retinopathy: an exploratory analysis. Eye (Lond). 2019;33(8):1240&#x02013;7.<pub-id pub-id-type="pmid">30903092</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR37"><label>37.</label><citation-alternatives><element-citation id="ec-CR37" publication-type="journal"><person-group person-group-type="author"><name><surname>Lupidi</surname><given-names>M</given-names></name><name><surname>Cerquaglia</surname><given-names>A</given-names></name><name><surname>Gujar</surname><given-names>R</given-names></name><etal/></person-group><article-title>Functional correlation between choroidal and retinal vascularity in low-grade diabetic retinopathy</article-title><source>Acta Diabetol</source><year>2020</year><volume>57</volume><issue>8</issue><fpage>983</fpage><lpage>90</lpage><pub-id pub-id-type="doi">10.1007/s00592-020-01507-7</pub-id><pub-id pub-id-type="pmid">32201906</pub-id>
</element-citation><mixed-citation id="mc-CR37" publication-type="journal">Lupidi M, Cerquaglia A, Gujar R, et al. Functional correlation between choroidal and retinal vascularity in low-grade diabetic retinopathy. Acta Diabetol. 2020;57(8):983&#x02013;90.<pub-id pub-id-type="pmid">32201906</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR38"><label>38.</label><citation-alternatives><element-citation id="ec-CR38" publication-type="journal"><person-group person-group-type="author"><name><surname>Yang</surname><given-names>D</given-names></name><name><surname>Cao</surname><given-names>D</given-names></name><name><surname>Huang</surname><given-names>Z</given-names></name><etal/></person-group><article-title>Macular capillary perfusion in Chinese patients with diabetic retinopathy obtained with optical coherence tomography angiography</article-title><source>Ophthalmic Surg Lasers Imaging Retina</source><year>2019</year><volume>50</volume><issue>4</issue><fpage>e88</fpage><lpage>95</lpage><pub-id pub-id-type="doi">10.3928/23258160-20190401-12</pub-id><pub-id pub-id-type="pmid">30998251</pub-id>
</element-citation><mixed-citation id="mc-CR38" publication-type="journal">Yang D, Cao D, Huang Z, et al. Macular capillary perfusion in Chinese patients with diabetic retinopathy obtained with optical coherence tomography angiography. Ophthalmic Surg Lasers Imaging Retina. 2019;50(4):e88&#x02013;95.<pub-id pub-id-type="pmid">30998251</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR39"><label>39.</label><citation-alternatives><element-citation id="ec-CR39" publication-type="journal"><person-group person-group-type="author"><name><surname>Ryu</surname><given-names>G</given-names></name><name><surname>Kim</surname><given-names>I</given-names></name><name><surname>Sagong</surname><given-names>M</given-names></name></person-group><article-title>Topographic analysis of retinal and choroidal microvasculature according to diabetic retinopathy severity using optical coherence tomography angiography</article-title><source>Graefes Arch Clin Exp Ophthalmol</source><year>2021</year><volume>259</volume><issue>1</issue><fpage>61</fpage><lpage>8</lpage><pub-id pub-id-type="doi">10.1007/s00417-020-04785-7</pub-id><pub-id pub-id-type="pmid">32648156</pub-id>
</element-citation><mixed-citation id="mc-CR39" publication-type="journal">Ryu G, Kim I, Sagong M. Topographic analysis of retinal and choroidal microvasculature according to diabetic retinopathy severity using optical coherence tomography angiography. Graefes Arch Clin Exp Ophthalmol. 2021;259(1):61&#x02013;8.<pub-id pub-id-type="pmid">32648156</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR40"><label>40.</label><citation-alternatives><element-citation id="ec-CR40" publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>W</given-names></name><name><surname>Cheng</surname><given-names>W</given-names></name><name><surname>Yang</surname><given-names>S</given-names></name><name><surname>Chen</surname><given-names>Y</given-names></name><name><surname>Zhu</surname><given-names>Z</given-names></name><name><surname>Huang</surname><given-names>W</given-names></name></person-group><article-title>Choriocapillaris flow deficit and the risk of referable diabetic retinopathy: a longitudinal SS-OCTA study</article-title><source>Br J Ophthalmol</source><year>2023</year><volume>107</volume><issue>9</issue><fpage>1319</fpage><lpage>23</lpage><pub-id pub-id-type="doi">10.1136/bjophthalmol-2021-320704</pub-id><pub-id pub-id-type="pmid">35577546</pub-id>
</element-citation><mixed-citation id="mc-CR40" publication-type="journal">Wang W, Cheng W, Yang S, Chen Y, Zhu Z, Huang W. Choriocapillaris flow deficit and the risk of referable diabetic retinopathy: a longitudinal SS-OCTA study. Br J Ophthalmol. 2023;107(9):1319&#x02013;23.<pub-id pub-id-type="pmid">35577546</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR41"><label>41.</label><citation-alternatives><element-citation id="ec-CR41" publication-type="journal"><person-group person-group-type="author"><name><surname>Liu</surname><given-names>T</given-names></name><name><surname>Lin</surname><given-names>W</given-names></name><name><surname>Shi</surname><given-names>G</given-names></name><etal/></person-group><article-title>Retinal and choroidal vascular perfusion and thickness measurement in diabetic retinopathy patients by the swept-source optical coherence tomography angiography</article-title><source>Front Med (Lausanne)</source><year>2022</year><volume>9</volume><fpage>786708</fpage><pub-id pub-id-type="doi">10.3389/fmed.2022.786708</pub-id><pub-id pub-id-type="pmid">35372401</pub-id>
</element-citation><mixed-citation id="mc-CR41" publication-type="journal">Liu T, Lin W, Shi G, et al. Retinal and choroidal vascular perfusion and thickness measurement in diabetic retinopathy patients by the swept-source optical coherence tomography angiography. Front Med (Lausanne). 2022;9:786708.<pub-id pub-id-type="pmid">35372401</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR42"><label>42.</label><mixed-citation publication-type="other">Ra H, Kang NY, Song J, Lee J, Kim I, Baek J. Discordance in retinal and choroidal vascular densities in patients with type 2 diabetes mellitus on optical coherence tomography angiography. J Ophthalmol. 2021; 2021: 8871602.</mixed-citation></ref><ref id="CR43"><label>43.</label><citation-alternatives><element-citation id="ec-CR43" publication-type="journal"><person-group person-group-type="author"><name><surname>Ghassemi</surname><given-names>F</given-names></name><name><surname>Fadakar</surname><given-names>K</given-names></name><name><surname>Berijani</surname><given-names>S</given-names></name><name><surname>Babeli</surname><given-names>A</given-names></name><name><surname>Gholizadeh</surname><given-names>A</given-names></name><name><surname>Sabour</surname><given-names>S</given-names></name></person-group><article-title>Quantitative assessment of vascular density in diabetic retinopathy subtypes with optical coherence tomography angiography</article-title><source>BMC Ophthalmol</source><year>2021</year><volume>21</volume><issue>1</issue><fpage>82</fpage><pub-id pub-id-type="doi">10.1186/s12886-021-01831-8</pub-id><pub-id pub-id-type="pmid">33579225</pub-id>
</element-citation><mixed-citation id="mc-CR43" publication-type="journal">Ghassemi F, Fadakar K, Berijani S, Babeli A, Gholizadeh A, Sabour S. Quantitative assessment of vascular density in diabetic retinopathy subtypes with optical coherence tomography angiography. BMC Ophthalmol. 2021;21(1):82.<pub-id pub-id-type="pmid">33579225</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR44"><label>44.</label><citation-alternatives><element-citation id="ec-CR44" publication-type="journal"><person-group person-group-type="author"><name><surname>Chen</surname><given-names>Y</given-names></name><name><surname>Zhu</surname><given-names>Z</given-names></name><name><surname>Cheng</surname><given-names>W</given-names></name><etal/></person-group><article-title>Choriocapillaris flow deficit as a biomarker for diabetic retinopathy and diabetic macular edema: 3-year longitudinal cohort</article-title><source>Am J Ophthalmol</source><year>2023</year><volume>248</volume><fpage>76</fpage><lpage>86</lpage><pub-id pub-id-type="doi">10.1016/j.ajo.2022.11.018</pub-id><pub-id pub-id-type="pmid">36436548</pub-id>
</element-citation><mixed-citation id="mc-CR44" publication-type="journal">Chen Y, Zhu Z, Cheng W, et al. Choriocapillaris flow deficit as a biomarker for diabetic retinopathy and diabetic macular edema: 3-year longitudinal cohort. Am J Ophthalmol. 2023;248:76&#x02013;86.<pub-id pub-id-type="pmid">36436548</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR45"><label>45.</label><citation-alternatives><element-citation id="ec-CR45" publication-type="journal"><person-group person-group-type="author"><name><surname>Guo</surname><given-names>X</given-names></name><name><surname>Chen</surname><given-names>Y</given-names></name><name><surname>Bulloch</surname><given-names>G</given-names></name><etal/></person-group><article-title>Parapapillary choroidal microvasculature predicts diabetic retinopathy progression and diabetic macular edema development: a three-year prospective study</article-title><source>Am J Ophthalmol</source><year>2023</year><volume>245</volume><fpage>164</fpage><lpage>73</lpage><pub-id pub-id-type="doi">10.1016/j.ajo.2022.07.008</pub-id><pub-id pub-id-type="pmid">35863493</pub-id>
</element-citation><mixed-citation id="mc-CR45" publication-type="journal">Guo X, Chen Y, Bulloch G, et al. Parapapillary choroidal microvasculature predicts diabetic retinopathy progression and diabetic macular edema development: a three-year prospective study. Am J Ophthalmol. 2023;245:164&#x02013;73.<pub-id pub-id-type="pmid">35863493</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR46"><label>46.</label><citation-alternatives><element-citation id="ec-CR46" publication-type="journal"><person-group person-group-type="author"><name><surname>Mastropasqua</surname><given-names>R</given-names></name><name><surname>D&#x02019;Aloisio</surname><given-names>R</given-names></name><name><surname>Di Antonio</surname><given-names>L</given-names></name><etal/></person-group><article-title>Widefield optical coherence tomography angiography in diabetic retinopathy</article-title><source>Acta Diabetol</source><year>2019</year><volume>56</volume><issue>12</issue><fpage>1293</fpage><lpage>303</lpage><pub-id pub-id-type="doi">10.1007/s00592-019-01410-w</pub-id><pub-id pub-id-type="pmid">31468199</pub-id>
</element-citation><mixed-citation id="mc-CR46" publication-type="journal">Mastropasqua R, D&#x02019;Aloisio R, Di Antonio L, et al. Widefield optical coherence tomography angiography in diabetic retinopathy. Acta Diabetol. 2019;56(12):1293&#x02013;303.<pub-id pub-id-type="pmid">31468199</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR47"><label>47.</label><citation-alternatives><element-citation id="ec-CR47" publication-type="journal"><person-group person-group-type="author"><name><surname>Coscas</surname><given-names>G</given-names></name><name><surname>Lupidi</surname><given-names>M</given-names></name><name><surname>Coscas</surname><given-names>F</given-names></name></person-group><article-title>Optical coherence tomography angiography in diabetic maculopathy</article-title><source>Dev Ophthalmol</source><year>2017</year><volume>60</volume><fpage>38</fpage><lpage>49</lpage><pub-id pub-id-type="doi">10.1159/000459688</pub-id><pub-id pub-id-type="pmid">28427063</pub-id>
</element-citation><mixed-citation id="mc-CR47" publication-type="journal">Coscas G, Lupidi M, Coscas F. Optical coherence tomography angiography in diabetic maculopathy. Dev Ophthalmol. 2017;60:38&#x02013;49.<pub-id pub-id-type="pmid">28427063</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR48"><label>48.</label><citation-alternatives><element-citation id="ec-CR48" publication-type="journal"><person-group person-group-type="author"><name><surname>Li</surname><given-names>L</given-names></name><name><surname>Almansoob</surname><given-names>S</given-names></name><name><surname>Zhang</surname><given-names>P</given-names></name><name><surname>Zhou</surname><given-names>YD</given-names></name><name><surname>Tan</surname><given-names>Y</given-names></name><name><surname>Gao</surname><given-names>L</given-names></name></person-group><article-title>Quantitative analysis of retinal and choroid capillary ischaemia using optical coherence tomography angiography in type 2 diabetes</article-title><source>Acta Ophthalmol</source><year>2019</year><volume>97</volume><issue>3</issue><fpage>240</fpage><lpage>6</lpage><pub-id pub-id-type="doi">10.1111/aos.14076</pub-id><pub-id pub-id-type="pmid">30810284</pub-id>
</element-citation><mixed-citation id="mc-CR48" publication-type="journal">Li L, Almansoob S, Zhang P, Zhou YD, Tan Y, Gao L. Quantitative analysis of retinal and choroid capillary ischaemia using optical coherence tomography angiography in type 2 diabetes. Acta Ophthalmol. 2019;97(3):240&#x02013;6.<pub-id pub-id-type="pmid">30810284</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR49"><label>49.</label><citation-alternatives><element-citation id="ec-CR49" publication-type="journal"><person-group person-group-type="author"><name><surname>Kaderli</surname><given-names>ST</given-names></name><name><surname>Karalezli</surname><given-names>A</given-names></name><name><surname>Kaya</surname><given-names>C</given-names></name><name><surname>Korkmaz</surname><given-names>S</given-names></name><name><surname>Sul</surname><given-names>S</given-names></name></person-group><article-title>Sensitivity and specificity of the optical coherence tomography angiography for detection of neovascularization and evaluation of peripheral ischemia in diabetic retinopathy</article-title><source>Beyoglu Eye J</source><year>2022</year><volume>7</volume><issue>4</issue><fpage>273</fpage><lpage>81</lpage><pub-id pub-id-type="pmid">36628081</pub-id>
</element-citation><mixed-citation id="mc-CR49" publication-type="journal">Kaderli ST, Karalezli A, Kaya C, Korkmaz S, Sul S. Sensitivity and specificity of the optical coherence tomography angiography for detection of neovascularization and evaluation of peripheral ischemia in diabetic retinopathy. Beyoglu Eye J. 2022;7(4):273&#x02013;81.<pub-id pub-id-type="pmid">36628081</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR50"><label>50.</label><citation-alternatives><element-citation id="ec-CR50" publication-type="journal"><person-group person-group-type="author"><name><surname>Bandello</surname><given-names>F</given-names></name><name><surname>Borrelli</surname><given-names>E</given-names></name><name><surname>Trevisi</surname><given-names>M</given-names></name><name><surname>Lattanzio</surname><given-names>R</given-names></name><name><surname>Sacconi</surname><given-names>R</given-names></name><name><surname>Querques</surname><given-names>G</given-names></name></person-group><article-title>Imaging biomarkers of mesopic and dark-adapted macular functions in eyes with treatment-na&#x000ef;ve mild diabetic retinopathy</article-title><source>Am J Ophthalmol</source><year>2023</year><volume>253</volume><fpage>56</fpage><lpage>64</lpage><pub-id pub-id-type="doi">10.1016/j.ajo.2023.04.005</pub-id><pub-id pub-id-type="pmid">37059317</pub-id>
</element-citation><mixed-citation id="mc-CR50" publication-type="journal">Bandello F, Borrelli E, Trevisi M, Lattanzio R, Sacconi R, Querques G. Imaging biomarkers of mesopic and dark-adapted macular functions in eyes with treatment-na&#x000ef;ve mild diabetic retinopathy. Am J Ophthalmol. 2023;253:56&#x02013;64.<pub-id pub-id-type="pmid">37059317</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR51"><label>51.</label><citation-alternatives><element-citation id="ec-CR51" publication-type="journal"><person-group person-group-type="author"><name><surname>Ro-Mase</surname><given-names>T</given-names></name><name><surname>Ishiko</surname><given-names>S</given-names></name><name><surname>Omae</surname><given-names>T</given-names></name><name><surname>Ishibazawa</surname><given-names>A</given-names></name><name><surname>Shimouchi</surname><given-names>A</given-names></name><name><surname>Yoshida</surname><given-names>A</given-names></name></person-group><article-title>Association between alterations of the choriocapillaris microcirculation and visual function and cone photoreceptors in patients with diabetes</article-title><source>Invest Ophthalmol Vis Sci</source><year>2020</year><volume>61</volume><issue>6</issue><fpage>1</fpage><pub-id pub-id-type="doi">10.1167/iovs.61.6.1</pub-id><pub-id pub-id-type="pmid">32492109</pub-id>
</element-citation><mixed-citation id="mc-CR51" publication-type="journal">Ro-Mase T, Ishiko S, Omae T, Ishibazawa A, Shimouchi A, Yoshida A. Association between alterations of the choriocapillaris microcirculation and visual function and cone photoreceptors in patients with diabetes. Invest Ophthalmol Vis Sci. 2020;61(6):1.<pub-id pub-id-type="pmid">32492109</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR52"><label>52.</label><citation-alternatives><element-citation id="ec-CR52" publication-type="journal"><person-group person-group-type="author"><name><surname>Viggiano</surname><given-names>P</given-names></name><name><surname>Costanzo</surname><given-names>E</given-names></name><name><surname>Giannini</surname><given-names>D</given-names></name><etal/></person-group><article-title>In vivo assessment of associations between photoreceptors structure and macular perfusion in type 1 diabetes</article-title><source>Br J Ophthalmol</source><year>2023</year><volume>107</volume><issue>11</issue><fpage>1672</fpage><lpage>9</lpage><pub-id pub-id-type="doi">10.1136/bjo-2022-321617</pub-id><pub-id pub-id-type="pmid">36126103</pub-id>
</element-citation><mixed-citation id="mc-CR52" publication-type="journal">Viggiano P, Costanzo E, Giannini D, et al. In vivo assessment of associations between photoreceptors structure and macular perfusion in type 1 diabetes. Br J Ophthalmol. 2023;107(11):1672&#x02013;9.<pub-id pub-id-type="pmid">36126103</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR53"><label>53.</label><citation-alternatives><element-citation id="ec-CR53" publication-type="journal"><person-group person-group-type="author"><name><surname>Parravano</surname><given-names>M</given-names></name><name><surname>Ziccardi</surname><given-names>L</given-names></name><name><surname>Borrelli</surname><given-names>E</given-names></name><etal/></person-group><article-title>Outer retina dysfunction and choriocapillaris impairment in type 1 diabetes</article-title><source>Sci Rep</source><year>2021</year><volume>11</volume><issue>1</issue><fpage>15183</fpage><pub-id pub-id-type="doi">10.1038/s41598-021-94580-z</pub-id><pub-id pub-id-type="pmid">34312425</pub-id>
</element-citation><mixed-citation id="mc-CR53" publication-type="journal">Parravano M, Ziccardi L, Borrelli E, et al. Outer retina dysfunction and choriocapillaris impairment in type 1 diabetes. Sci Rep. 2021;11(1):15183.<pub-id pub-id-type="pmid">34312425</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR54"><label>54.</label><citation-alternatives><element-citation id="ec-CR54" publication-type="journal"><person-group person-group-type="author"><name><surname>Borrelli</surname><given-names>E</given-names></name><name><surname>Palmieri</surname><given-names>M</given-names></name><name><surname>Viggiano</surname><given-names>P</given-names></name><name><surname>Ferro</surname><given-names>G</given-names></name><name><surname>Mastropasqua</surname><given-names>R</given-names></name></person-group><article-title>Photoreceptor damage in diabetic choroidopathy</article-title><source>Retina</source><year>2020</year><volume>40</volume><issue>6</issue><fpage>1062</fpage><lpage>9</lpage><pub-id pub-id-type="doi">10.1097/IAE.0000000000002538</pub-id><pub-id pub-id-type="pmid">30986798</pub-id>
</element-citation><mixed-citation id="mc-CR54" publication-type="journal">Borrelli E, Palmieri M, Viggiano P, Ferro G, Mastropasqua R. Photoreceptor damage in diabetic choroidopathy. Retina. 2020;40(6):1062&#x02013;9.<pub-id pub-id-type="pmid">30986798</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR55"><label>55.</label><citation-alternatives><element-citation id="ec-CR55" publication-type="journal"><person-group person-group-type="author"><name><surname>Ucgul Atilgan</surname><given-names>C</given-names></name><name><surname>Atilgan</surname><given-names>KG</given-names></name><name><surname>Kosekahya</surname><given-names>P</given-names></name><etal/></person-group><article-title>Retinal microcirculation alterations in microalbuminuric diabetic patients with and without retinopathy</article-title><source>Semin Ophthalmol</source><year>2021</year><volume>36</volume><issue>5&#x02013;6</issue><fpage>406</fpage><lpage>12</lpage><pub-id pub-id-type="doi">10.1080/08820538.2021.1896745</pub-id><pub-id pub-id-type="pmid">33689564</pub-id>
</element-citation><mixed-citation id="mc-CR55" publication-type="journal">Ucgul Atilgan C, Atilgan KG, Kosekahya P, et al. Retinal microcirculation alterations in microalbuminuric diabetic patients with and without retinopathy. Semin Ophthalmol. 2021;36(5&#x02013;6):406&#x02013;12.<pub-id pub-id-type="pmid">33689564</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR56"><label>56.</label><citation-alternatives><element-citation id="ec-CR56" publication-type="journal"><person-group person-group-type="author"><name><surname>Cao</surname><given-names>D</given-names></name><name><surname>Yang</surname><given-names>D</given-names></name><name><surname>Huang</surname><given-names>Z</given-names></name><etal/></person-group><article-title>Optical coherence tomography angiography discerns preclinical diabetic retinopathy in eyes of patients with type 2 diabetes without clinical diabetic retinopathy</article-title><source>Acta Diabetol</source><year>2018</year><volume>55</volume><issue>5</issue><fpage>469</fpage><lpage>77</lpage><pub-id pub-id-type="doi">10.1007/s00592-018-1115-1</pub-id><pub-id pub-id-type="pmid">29453673</pub-id>
</element-citation><mixed-citation id="mc-CR56" publication-type="journal">Cao D, Yang D, Huang Z, et al. Optical coherence tomography angiography discerns preclinical diabetic retinopathy in eyes of patients with type 2 diabetes without clinical diabetic retinopathy. Acta Diabetol. 2018;55(5):469&#x02013;77.<pub-id pub-id-type="pmid">29453673</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR57"><label>57.</label><mixed-citation publication-type="other">Scuderi L, Fragiotta S, Di Pippo M, Abdolrahimzadeh S. The role of diabetic choroidopathy in the pathogenesis and progression of diabetic retinopathy. Int J Mol Sci 2023; 24(12).</mixed-citation></ref></ref-list></back></article>